The Internets got agitated recently at the news that Moderna’s CEO, Stephane Bancel, dumped $400Million in Moderna stocks and nuked his Twitter account. Here’s why this shouldn’t surprise you and you should expect the worst any moment now.

Developing story, to be updated

Have you watched the former Blackrock director that went on Bannon’s War Room and prophesied that the Covid vaccines are a bubble that’s about to pop? Everything I’ve learned lately stands to support his claim.

This is him on Twitter:

If the dumping were a sudden and unusual move, this would indicate a recent event that shook the system, possibly rats leaving a sinking ship, a near threat for the business, as in:

That’s the case only partly, due to the stock crash overlapped with the incoming financial report, but a constant behavior over the span of months and years rather indicate a strategy and it’s associated with insider trading more often than not.

Surprisingly, it’s NPR of all the fakestream media who came in support of my suspicions, with a pretty merciless analysis of Moderna’s leadership financial behavior. And you know what’s funny? The piece dates all the way back to September 2020. I recommend reading the whole piece, I added the bolding and highlights :

Whether the coronavirus vaccine developed by Moderna succeeds or not, executives at the small biotech company have already made tens of millions of dollars by cashing in their stock. An NPR examination of official company disclosures has revealed additional irregularities and potential warning signs.

“On a scale of one to 10, one being less concerned and 10 being the most concerned,” said Daniel Taylor, an associate professor of accounting at the Wharton School, “this is an 11.”

Taylor said Moderna’s stock-selling practices appear well outside the norm, and raise questions about the company’s internal controls to prevent insider trading.

Since January, CEO Stéphane Bancel has sold roughly $40 million worth of Moderna stock held by himself or associated investment funds; Chief Medical Officer Tal Zaks has sold around $60 million; and President Stephen Hoge has sold more than $10 million.

Stéphane Bancel, chief executive officer of Moderna, has sold roughly $40 million worth of stock in the company since the beginning of this year.

The stock sales first came to widespread notice after Moderna announced positive early data from a vaccine trial in May [2020 – S.m.]. At that point, the company’s share price jumped and official disclosures showed executives cashing in their shares for millions of dollars.

“As long as stocks are sold after public announcements – and not before – one might conclude that for an executive with significant net worth tied up in the company, it’s a prudent thing to do,” said Marc Fagel, a former longtime enforcement official with the Securities And Exchange Commission (SEC). “But the optics aren’t great.”

The Moderna vaccine was quick to reach a phase 3 trial, and is seen as a promising contender. But, in some ways, the executives’ stock sales have overshadowed the company’s progress.

Advocates have questioned whether it’s appropriate for executives to privately profit before bringing the vaccine to market, especially when American taxpayers have committed roughly $2.5 billion to the company’s vaccine development and manufacture.

Here’s what NPR’s examination found:

  • Stock Sales Worth Tens Of Millions: Since June 1, NPR has found, company executives have sold roughly $90 million worth of Moderna stock. Rather than put a hold on the trades after facing intense criticism in May, company executives continued to sell.
  • Questionable Modifications To Stock Sale Plans: Moderna says its executives pre-scheduled their stock sales long in advance. Those schedules – known as 10b5-1 plans – can act as a defense to charges of insider trading. But the plans have to be put in place when executives do not have confidential inside information. NPR has found multiple executives adopted or modified their plans just before key announcements about the company’s vaccine. That has raised questions about whether they were aware of nonpublic information when they planned their stock trades.
  • Selling To Zero: Generally, corporate best practices suggest that a company’s leadership should hold on to at least some stock in their company to have “skin in the game.” That way, the thinking goes, an executive has an incentive to improve the company’s performance. As Moderna has been developing its coronavirus vaccine, two executives, including the Chief Medical Officer, have sold all their stock holdings in the company. The General Counsel has sold nearly all of her holdings.

In an interview with NPR, Ray Jordan, Moderna’s Chief Corporate Affairs Officer, said the company has strict internal policies in place to prevent illegal insider trading. For example, Jordan said, the company only allows employees to make changes to their stock sale schedules when they don’t have confidential inside information that could affect the company’s share price.

NPR asked Jordan why Moderna executives modified their 10b5-1 plans just before major announcements. Initially, Jordan said by email, “I believe you must have your dates wrong.”

NPR then provided documentation of those dates from the company’s official disclosures to the government, which Jordan did not dispute.

Jordan then said that even though multiple Moderna executives changed their 10b5-1 plans within one business day of announcements, the company had determined that those executives did not have “material nonpublic information” – a key term for insider trading – when they made those changes.

A spokesperson for the SEC declined to comment for this story.

From a relative unknown, to a key player in the vaccine race

Moderna launched in 2010 with a headquarters based in Cambridge, Mass., focused on using a technology called messenger RNA (or mRNA) to develop vaccines and therapeutics. The mRNA technology has been widely considered innovative, but remains largely unproven. The company has never brought a product to market. In early January, Moderna was trading for under $20 per share, and was valued at around six billion dollars.

Then Moderna announced that it had started collaborating on a coronavirus vaccine with scientists from the National Institute of Allergy and Infectious Diseases, which is led by Dr. Anthony Fauci.

By April, the government had committed half a billion dollars to the Moderna vaccine project as part of Operation Warp Speed.

Since then, the company’s stock price has exploded. Press releases suggesting positive news from the scientific trials, or announcing additional commitments of taxpayer funding sent the share price to a peak of around $95, before dropping to between $60-$70 in recent months. The company is now valued at around $25 billion.

As a result, shares owned by Moderna executives suddenly became much more valuable. And those executives have cashed in tens of millions of dollars worth of stock, according to filings with the SEC.

The bad press and critical comments did not deter continued sales. Since June 1, NPR found, executives sold around $90 million worth of stock.

Public money, private gain

The U.S. government is making massive financial bets on several vaccine candidates. In all likelihood, only some of those vaccine candidates will prove sufficiently safe and effective.

“If the vaccine doesn’t work, you lost a lot of money,” Fauci has said. “But we feel this is serious enough that it’s worth the financial risk.”

But even if taxpayers lose money betting on Moderna, the company’s executives have already made millions.

“The insiders are making plenty of profit and they’re mostly doing it with our money,” said Margarida Jorge, a campaign director with the group Lower Drug Prices Now. “I’m absolutely for deploying public money in the interests of public health and the public good. But we don’t have any commitment from the administration that any of this investment is ultimately going to benefit real people.”

Moderna has argued that the company was only in a position to work with the government on a coronavirus vaccine, because it had spent a decade developing its mRNA technology with the support of private investors.

“The company has been funded over the years by billions of dollars of private investment,” Zaks told the Freakonomics podcast in August. “Those billions created the opportunity for the U.S. government to come in earlier this year and say, ‘I’m going to add some money to the pot to make sure that you get the development for this vaccine right.'”

[But they locked in the Government and its funding for mRNA technology years before SARS-COV2, as shown below, so this was a deliberate lie – S.m]
Trying to resuscitate the company with some archive work?

“Set it and forget it” stock plans

Moderna has offered another defense of those stock sales: the sales, representatives and executives say, were scheduled well in advance, and were unrelated to the market-moving announcements about the coronavirus vaccine. An NPR examination of the company’s financial filings tells a more complicated story.

The schedules are known as 10b5-1 plans. If your stock trades are on autopilot, the idea goes, then you can’t be accused of insider trading. But these “set it and forget it” plans have to be adopted when executives do not have “material nonpublic information,” to use the legal term.

In an interview with CNBC in July, CEO Bancel said he and other executives set up their 10b5-1 plans “a long time ago” – in December 2018 – and “obviously, when we set up those plans, none of us had any idea what was going to happen in 2020.”

In fact, NPR has found, Moderna executives, including Bancel himself, implemented new plans or modified older plans at multiple points in 2020, and right around key announcements related to the company’s vaccine.

On Jan. 21, 2020, for example, Chief Medical Officer Dr. Tal Zaks amended his 10b5-1 plan. (It’s unclear what changes he made.)

Then, on Jan. 22, Moderna first widely confirmed that it was working with the government on a coronavirus vaccine. The following day, Jan. 23, the company announced it had received additional funding to support its coronavirus vaccine development.

NPR asked Moderna whether Zaks might have been aware of the collaboration with the government when he changed his stock trading plan.

“What was known on that particular day or not known, I couldn’t specifically talk to,” Moderna’s Jordan told NPR. But he said that the Moderna legal team only allows employees to change their 10b5-1 plans if they do not possess inside information that could affect the company’s share price.

Later, on Friday, March 13, three Moderna executives adopted new 10b5-1 plans, according to records reviewed by NPR: Zaks, Chief Technical Operations and Quality Officer Juan Andres, and then-Chief Financial Officer Lorence H. Kim. (Kim left the company in August 2020.)

On Monday, March 16 – one business day later – the company announced that it had given a participant the first dose of their vaccine as part of its phase 1 trial. The stock ended that day up 24% compared to the previous day’s close. Moderna was “bucking the trend” of the broader market, which was panicking over coronavirus fears, one CNBC host said at the time.

Timing Of Changes To Pre-Scheduled Stock Sales Raises Questions

Jan. 21 – Chief Medical Officer Dr. Tal Zaks amends his schedule of stock sales, known as a 10b5-1 plan.

Jan. 22 – Moderna widely confirms that it is working on a coronavirus vaccine with the National Institutes of Health. The company’s share price rises nearly 5% over the previous day’s close.

Jan. 23 – Moderna announces new funding from the Coalition for Epidemic Preparedness Innovations.

Mar. 13 – Chief Technical Operations Officer Juan Andres, Chief Financial Officer Lorence Kim, and Zaks adopt new 10b5-1 trading plans.

Mar. 16 – Moderna announces that it provided the first dose of its coronavirus vaccine to a participant in a phase 1 trial. Moderna stock climbs 24% over the previous day’s close.

May 18 – Moderna reports early positive data from its phase 1 trial. The company’s stock ends the day up 20% over the previous day’s close.

May 21 – CEO Stéphane Bancel adopts and amends multiple 10b5-1 trading plans.

May 29 – Moderna announces another milestone in its phase 2 coronavirus vaccine trial.

June 1 – President Stephen Hoge amends his 10b5-1 plan.

Despite the close timing, Jordan told NPR, “by the judgment of the legal team, there would not have been material, nonpublic information known” when executives entered into the new plans.

“Every company and individual is entitled to the presumption of innocence. That said, from the public’s perspective, this trading behavior looks very problematic,” said Taylor of the Wharton School, who first pointed out the timing of these changes to NPR.

“If I put on my SEC enforcement hat, I would certainly be asking, ‘What caused you to change the plan on a Friday?'” said Kurt Wolfe, who works as a defense attorney in securities cases for the firm Troutman Pepper. “I don’t think it’s a good fact pattern.”

On May 21 – in between announcements of major vaccine trial milestones on May 18 and May 29 – CEO Bancel amended and adopted 10b5-1 plans. And on June 1, President Hoge amended his trading plan.

“Amending a trading plan after a positive announcement, like trading after a positive announcement, is only problematic if the executive possesses material, nonpublic information at the time,” said Fagel. “Though repeated or questionably-timed changes to a trading plan will reduce its value as a defense to insider trading.”

Selling to zero

Using these 10b5-1 plans, two Moderna executives – Zaks and Andres – have sold all of their shares in the company. General Counsel Lori Henderson has sold nearly all of her shares.

In fact, roughly every week since June, Zaks has exercised stock options (meaning, he bought stock at a price set by the company as part of his compensation), and then immediately sold all of his shares for a significant profit.

[Isn’t this a great explanation for Bancel’s sales too?! – S.m]


On Aug. 24, for example, Zaks exercised stock options and bought 25,000 shares at bargain prices of between $12 to $21. He then immediately sold all of those shares for around $65 per share. Zaks ended up with a profit of nearly $1.2 million.

SEC filings indicate these trades are made under the 10b5-1 plan he adopted in March.

Selling so much stock can also raise concerns for investors – and the public – about why company leaders would sell now if they expected their vaccine to succeed later. After all, a safe and effective vaccine could send Moderna’s stock to even greater heights.

“It perhaps draws questions about how much they believe in it,” said Wolfe.

If the company does develop a safe and effective coronavirus vaccine, and its stock keeps rising, then “these trades will be water under the bridge,” said Fagel, the former SEC enforcement official.

But, Fagel warns, if the vaccine fails, then SEC regulators and angry investors may come looking for answers. In that case, he said, “both class action litigation and an SEC investigation would seem inevitable.”

NPR revelations end here, we’re actually just starting

So what we’ve learned is that Moderna looks like a stock market operation more than a medical one. The chiefs create momentums and then trade. And they use public money to bet and make billions, but more about that shortly.

This news is actually pretext to get you to know the real history of Moderna, a crux point in modern history in the widest sense. The stock dumping is not really news, it’s been happening for quite a while, indicating a long term strategy and business model, rather than a sudden or impulse move.

The next two older reports from Pharma’s own media – STAT, will cement the certainty that Moderna turned into a stock market bubble long ago, under the helms of Stephan Bancel. They don’t mind having some science to show, but that’s just the bait.

Ego, ambition, and turmoil: Inside one of biotech’s most secretive startups

By Damian Garde for STAT, Sept. 13, 2016

At first glance, Moderna Therapeutics looks like the most enviable biotech startup in the world. It has smashed fundraising records and teamed up with pharmaceutical giants as it pursues a radical plan to revolutionize medicine by transforming human cells into drug factories.

But the reality is more complicated.

A STAT investigation found that the company’s caustic work environment has for years driven away top talent and that behind its obsession with secrecy, there are signs Moderna has run into roadblocks with its most ambitious projects.

At the center of it all is Stéphane Bancel, a first-time biotech CEO with an unwavering belief that Moderna’s science will work — and that employees who don’t “live the mission” have no place in the company. Confident and intense, Bancel told STAT that Moderna’s science is on track and, when it is finally made public, that it will meet the brash goal he himself has set: The new drugs will change the world.

But interviews with more than 20 current and former employees and associates suggest Bancel has hampered progress at Moderna because of his ego, his need to assert control and his impatience with the setbacks that are an inevitable part of scienceModerna is worth more than any other private biotech in the US, and former employees said they felt that Bancel prized the company’s ever-increasing valuation, now approaching $5 billion, over its science.

As he pursued a complex and risky strategy for drug development, Bancel built a culture of recrimination at Moderna, former employees said. Failed experiments have been met with reprimands and even on-the-spot firings. They recalled abusive emails, dressings down at company meetings, exceedingly long hours, and unexplained terminations.

At least a dozen highly placed executives have quit in the past four years, including heads of finance, technology, manufacturing, and science. In just the past 12 months, respected leaders of Moderna’s cancer and rare disease programs both resigned, even though the company’s remarkable fundraising had put ample resources at their disposal. Each had been at the company less than 18 months, and the positions have yet to be filled.

Lower-ranking employees, meanwhile, said they’ve been disappointed and confused by Moderna’s pivot to less ambitious — and less transformative — treatments. Moderna has pushed off projects meant to upend the drug industry to focus first on the less daunting (and most likely, far less lucrative) field of vaccines — though it is years behind competitors in that arena.

The company has published no data supporting its vaunted technology, and it’s so secretive that some job candidates have to sign nondisclosure agreements before they come in to interview. Outside venture capitalists said Moderna has so many investors clamoring to get in that it can afford to turn away any who ask too many questions. Some small players have been given only a peek at Moderna’s data before committing millions to the company, according to people familiar with the matter.

“It’s a case of the emperor’s new clothes,” said a former Moderna scientist. “They’re running an investment firm, and then hopefully it also develops a drug that’s successful.”

Like many employees and former employees, the scientist requested anonymity because of a nondisclosure agreement. Others would not permit their names to be published out of fear that speaking candidly about big players in the industry would hurt their job prospects down the road.

Moderna just moved its first two potential treatments — both vaccines — into human trials. In keeping with the culture of secrecy, though, executives won’t say which diseases the vaccines target, and they have not listed the studies on the public federal registry, ClinicalTrials.gov. Listing is optional for Phase 1 trials, which are meant to determine if a drug is safe, but most companies voluntarily disclose their work.

Investors say it’ll be worth the wait when the company finally lifts the veil.

“We think that when the world does get to see Moderna, they’re going to see something far larger in its scope than anybody’s seen before,” said Peter Kolchinsky, whose RA Capital Management owns a stake in the company.

Moderna
The Moderna offices in Cambridge, Mass.ARAM BOGHOSIAN FOR STAT

Bancel, meanwhile, said he is aware of the criticism of him and has taken some steps to address it. After scathing anonymous comments about Moderna’s management began showing up online, Bancel went to Silicon Valley to get tips on employee retention from the human resources departments of Facebook, Google, and Netflix. But he makes no apologies for tumult past or present, pointing to the thousands of patients who might be saved by Moderna’s technology.

“You want to be the guy who’s going to fail them? I don’t,” he said in an interview from his glassy third-floor office. “So was it an intense place? It was. And do I feel sorry about it? No.”

An ambitious CEO dreams big

Bancel, 44, had no experience running a drug development operation when one of biotech’s most successful venture capitalists tapped him to lead Moderna. He’d spent most of his career in sales and operations, not science.

But he had made no secret of his ambition.

A native of France, Bancel earned a master’s in chemical engineering from the University of Minnesota and an MBA from Harvard in 2000. As Harvard Business School classmates rushed to cash in on the dot-com boom, Bancel laid out a plan to play “chess, not checkers.”

“I was always thinking, one day, somebody will have to make a decision about me getting a CEO job,” he told an audience at his alma mater in April. “… How do I make sure I’m not the bridesmaid? How do I make sure that I’m not always the person who’s almost selected but doesn’t get the role?”

He went into sales and rose through the operational ranks at pharmaceutical giant Eli Lilly, eventually leading the company’s Belgian operation. And in 2007, at just 34, he achieved his goal, stepping in as CEO of the French diagnostics firm bioMérieux, which employs roughly 6,000 people.

The company improved its margins under Bancel’s tenure, and he developed a reputation as a stern manager who got results, according to an equities analyst who covered bioMérieux at the time.

“He doesn’t suffer fools lightly,” the analyst said, speaking on condition of anonymity to comply with company policy. “I think if you’re underperforming, you’ll probably find yourself looking for another job.”

Bancel’s rise caught the eye of the biotech investment firm Flagship Ventures, based here in Cambridge. Flagship CEO Noubar Afeyan repeatedly tried to entice him to take over one of the firm’s many startups, Bancel said. But he rejected one prospect after another because the startups seemed too narrow in scope.

Moderna was different.

The company’s core idea was seductively simple: cut out the middleman in biotech.

For decades, companies have endeavored to craft better and better protein therapies, leading to new treatments for cancer, autoimmune disorders, and rare diseases. Such therapies are costly to produce and have many limitations, but they’ve given rise to a multibillion-dollar industry. The anti-inflammatory Humira, the world’s top drug at $14 billion in sales a year, is a shining example of protein therapy.

Moderna’s technology promised to subvert the whole field, creating therapeutic proteins inside the body instead of in manufacturing plants. The key: harnessing messenger RNA, or mRNA.

In nature, mRNA molecules function like recipe books, directing cellular machinery to make specific proteins. Moderna believes it can play that system to its advantage by using synthetic mRNA to compel cells to produce whichever proteins it chooses. In effect, the mRNA would turn cells into tiny drug factories.

It’s highly risky. Big pharma companies had tried similar work and abandoned it because it’s exceedingly hard to get RNA into cells without triggering nasty side effects. But if Moderna can get it to work, the process could be used to treat scores of diseases, including cancers and rare diseases that can be death sentences for children.

Bancel was intrigued. He knew it was a gamble, he told STAT, “but if I don’t do it, and it works, I’m just going to kick myself every morning.”

And so he became the company’s CEO — and soon developed an almost messianic reverence for the mRNA technology.

Despite having never worked with RNA before, Bancel said he sat around the table with his core team in the early days of the company, dreaming up experiments. As a result, he is listed as a co-inventor on more than 100 of Moderna’s early patent applications, unusual for a CEO who is not a PhD scientist.

Lavishly funded Moderna hits safety problems in bold bid to revolutionize medicine

By Damian Garde, STAT, Jan. 10, 2017

SAN FRANCISCO — Moderna Therapeutics, the most highly valued private company in biotech, has run into troubling safety problems with its most ambitious therapy, STAT has learned — and is now banking on a mysterious new technology to keep afloat its brash promise of reinventing modern medicine.

Exactly one year ago, Moderna CEO Stéphane Bancel talked up his company’s “unbelievable” future before a standing-room-only crowd at the annual J.P. Morgan Healthcare Conference here. He promised that Moderna’s treatment for a rare and debilitating disease known as Crigler-Najjar syndrome, developed alongside biotech giant Alexion Pharmaceuticals, would enter human trials in 2016.

It was to be the first therapy using audacious new technology that Bancel promised would yield dozens of drugs in the coming decade.

But the Crigler-Najjar treatment has been indefinitely delayed, an Alexion spokeswoman told STAT. It never proved safe enough to test in humans, according to several former Moderna employees and collaborators who worked closely on the project. Unable to press forward with that technology, Moderna has had to focus instead on developing a handful of vaccines, turning to a less lucrative field that might not justify the company’s nearly $5 billion valuation.

“It’s all vaccines right now, and vaccines are a loss-leader,” said one former Moderna manager. “Moderna right now is a multibillion-dollar vaccines company, and I don’t see how that holds up.”

Bancel made no mention of the Crigler-Najjar drug when he spoke Monday before a similarly packed room at this year’s J.P. Morgan conference.

His presentation instead focused on four vaccines that the company is moving through the first phase of clinical trials: two target strains of influenza, a third is for Zika virus, and the fourth remains a secret. Bancel clicked through graphs of data from animal studies before hurrying on to tout Moderna’s balance sheet and discuss the company’s cancer vaccines, slated for clinical testing later this year.

When STAT asked Bancel after the presentation about Crigler-Najjar, he deferred to Alexion.

In need of a Hail Mary

Founded in 2012, Moderna reached unicorn status — a $1 billion valuation — in just two years, faster than Uber, Dropbox, and Lyft, according to CB Insights. The company’s premise: Using custom-built strands of messenger RNA, known as mRNA, it aims to turn the body’s cells into ad hoc drug factories, compelling them to produce the proteins needed to treat a wide variety of diseases.

But mRNA is a tricky technology. Several major pharmaceutical companies have tried and abandoned the idea, struggling to get mRNA into cells without triggering nasty side effects.

Bancel has repeatedly promised that Moderna’s new therapies will change the world, but the company has refused to publish any data on its mRNA vehicles, sparking skepticism from some scientists and a chiding from the editors of Nature.

The indefinite delay on the Crigler-Najjar project signals persistent and troubling safety concerns for any mRNA treatment that needs to be delivered in multiple doses, covering almost everything that isn’t a vaccine, former employees and collaborators said.

The company did disclose a new technology on Monday that it says will more safely deliver mRNA. It’s called V1GL. Last month, Bancel told Forbes about another new technology, N1GL.

But in neither case has the company provided any details. And that lack of specificity has inevitably raised questions.

Three former employees and collaborators close to the process said Moderna was always toiling away on new delivery technologies in hopes of hitting on something safer than what it had. (Even Bancel has acknowledged, in an interview with Forbes, that the delivery method used in Moderna’s first vaccines “was not very good.”)

Are N1GL and V1GL better? The company has produced no data to answer that question. When STAT asked about new technologies, Bancel referred questions to the company’s patent filings.

The three former employees and collaborators said they believe N1GL and V1GL are either very recent discoveries, just in the earliest stages of testing — or else new names slapped on technologies Moderna has owned for years.

“[The technology] would have to be a miraculous, Hail Mary sort of save for them to get to where they need to be on their timelines,” one former employee said. “Either [Bancel] is extremely confident that it’s going to work, or he’s getting kind of jittery that with a lack of progress he needs to put something out there.”

Former employees and collaborators who spoke with STAT requested anonymity because they had signed nondisclosure agreements — which the highly secretive Moderna requires even some job candidates to sign.

STAT investigation last year found that Bancel had driven away top talent from Moderna with a culture of recrimination and a caustic work environment, including on-the-spot firings for failed experiments.

The company, based in Cambridge, Mass., seems to have repaired its reputation among many rank-and-file employees, winning workplace accolades from Science Magazine and the Boston Globe, but Moderna has lost more than a dozen top scientists and managers in the past four years, despite its vast financial resources.

A bug in the software

Bancel, a first-time biotech CEO, has dismissed questions about Moderna’s potential. He describes mRNA as a simple way to develop treatments for scores of ailments. As he told STAT over the summer, “mRNA is like software: You can just turn the crank and get a lot of products going into development.”

Related: SOFTWARE OF LIFE™ IS A MODERNA TRADE MARK FOR MRNA. LITERALLY. AND THEY MAKE APPS

It seems clear, however, that the software has run into bugs.

Patients with Crigler-Najjar are missing a key liver enzyme needed to break down bilirubin, a yellowish substance that crops up in the body as old red blood cells break down. Without that enzyme, bilirubin proliferates in the blood, leading to jaundice, muscle degeneration, and even brain damage.

In Moderna’s eyes, the one-in-million disease looked like an ideal candidate for mRNA therapy. The company crafted a string of mRNA that would encode for the missing enzyme, believing it had hit upon an excellent starting point to prove technology could be used to treat rare diseases.

But things gradually came apart last year.

Every drug has what’s called a therapeutic window, the scientific sweet spot where a treatment is powerful enough to have an effect on a disease but not so strong as to put patients at too much risk. For mRNA, that has proved elusive.

STAT
mRNA jabs are “rewriting the Genetic Code” we call it “information therapy” – Tal Zaks (Ted 2017)

Before COVID-19, the company’s secretive nature, and its failure to deliver a functional product, was drawing comparisons to the infamous biotech startup Theranos. Similar to Moderna, Theranos rarely published any peer-reviewed material. Like Moderna, Theranos mastered the networking game, and recruited high profile individuals to its board in order to vouch for the company’s “revolutionary technologies.” Once valued at well over $10 Billion, Theranos collapsed after it was revealed that the company was running a massive fraud scheme, in addition to its failure to implement its promised blood testing technology.

Jordan Schachtel @JordanSchachtelIn 2015, Dr John Ioannidis published a paper calling attention to Theranos & the shady biotech unicorn industry. Moderna is mentioned as a company that is following the Theranos path of zero disclosures, & publishing zero papers on their “innovative” tech. onlinelibrary.wiley.com/doi/epdf/10.11…
April 15th 2021113 Retweets281 Likes

Moderna’s Mysterious Medicines

FORBES EDITORS’ PICK |Dec 14, 2016

Excerpts:

“Now an obscure lawsuit filed in British Columbia in October sheds light on one of Moderna’s key partners, and through it FORBES can reveal details on Moderna’s amazing but still untested technology.

It appears that the first two products Moderna has entered into clinical trials rely on technology from a small outfit in Vancouver, British Columbia, called Acuitas Therapeutics. (Acuitas is so small, in fact, that its worldwide headquarters are in its CEO’s single-family home.)

Almost all medicines either block proteins–the building blocks of life–or, in the case of expensive biotech drugs, are proteins themselves. But Moderna has been promising to hack an entirely different part of life’s cookbook. In order to turn genetic information encoded in DNA into the cellular machines that actually are proteins, living things use a messenger chemical called mRNA.

Creating these mRNA drugs is a big challenge on many levels. For them to work, Moderna needs to deliver mRNA to the body’s cells. By itself mRNA breaks down in the bloodstream. Tiny Acuitas specializes in one method: lipid-nanoparticle delivery systems. Its technology essentially wraps the mRNA into balls of fat that disguise the drug so that the target cells will readily ingest it.

“Although we are small,” says Thomas Madden, chief executive of Acuitas, “I believe the technology we have developed is highly effective.”

The problem for Madden and Moderna is that Acuitas doesn’t actually own the technology it has licensed to Moderna. The tech belongs to a third company, publicly traded Arbutus, which recently decided to terminate the license for the tech that it had granted to Acuitas. That’s why Acuitas filed the lawsuit in British Columbia, to protect the deal it had. Arbutus immediately countersued, claiming its deal with Acuitas didn’t cover Moderna’s medicines.

The legal mess has its roots in Moderna’s 2011 start, when Robert Langer, an MIT professor, Moderna board member and founder of dozens of biotech companies, told Bancel that Moderna was too underfunded and small to create its own delivery system. So Moderna vetted over a dozen external delivery methods for mRNA and settled on at least three. One belonged to Arbutus, but Moderna turned to tiny Acuitas to get access to it.

Acuitas was formed in 2009 by Madden after a merger eliminated his position at Arbutus’ predecessor, Tekmira Pharmaceuticals. After a contentious lawsuit Madden was able to license from his former employer the novel tech he had helped develop, and Bancel claims Moderna chose to work with Acuitas because it had “the people and the capabilities.”

But that doesn’t explain why Moderna–flush with capital–didn’t make sure that sublicensing through Acuitas would be okay with Arbutus before advancing its new drugs into human studies.

Bancel met with FORBES at a Brooklyn coffee shop on a recent Saturday to dispel the implications of the lawsuit. He is dismissive of Acuitas’ technology. “We knew it was not very good,” he says. “It was just okay.”

He further explains that Moderna is in the process of producing its own nanoparticle lipids. One such lipid, N1GEL (called “Nigel” internally), appears to cause less inflammation than Acuitas’ version. Another is being licensed from Merck. Bancel says Moderna has stopped using the Acuitas tech for new drugs.

That still leaves a somewhat messy situation for any Moderna vaccines that are being developed using Acuitas’ tech.

Data from one vaccine is expected early next year. If results are good, it could lead to a sizzling-hot initial public offering, even if the Canadian lawsuit ultimately affords Arbutus bigger royalty payments from Moderna.”

Well, the two tiny Canadian companies mentioned above bring royalties to the Canada’s treasury (should I say The British Crown?), so don’t expect Trudeau to backpedal too soon

AND IF ONLY THEY HUSSLED WITH PRIVATE FUNDS, AS THEY CLAIMED…

Moderna chief keep claiming that they started to use public funds only as a patch on infrastructure, science and funding they’ve built for years.

Wrong!

It’s known that NIH + NIAID have long been one of their main sources for the “lavish funding” mentioned earlier and when they locked in the government support, they actually started to leverage it and attract even more private funds, in an self-feeding loop that created today’s monster-bubble.

Very few people know they even got money from BARDA and DARPA. As in “military funds”.

Remember this lie from earlier?
“The company has been funded over the years by billions of dollars of private investment,” Zaks told the Freakonomics podcast in August. “Those billions created the opportunity for the U.S. government to come in earlier this year and say, ‘I’m going to add some money to the pot to make sure that you get the development for this vaccine right.'”
Watch this claim getting nuked:

Taken from:

This grid above looks familiar to you? It does to me, but it’s not blood from people who underwent Covid genetic therapies, just something similar. Taken from:

KEI asks DOD to investigate failure to disclose DARPA funding in Moderna patents

  by  Knowledge Ecology International (KEI)

Luis Gil Abinader has taken a deep dive into Moderna’s surprising practice of never declaring government funding in its 126 patents and 154 patent applications, despite having had funding from multiple federal agencies.

One outcome of his research is a 25 page report (RN-2020-3) on Moderna’s failure to report funding from DARPA, and a request by KEI to DOD and DARPA to remedy this, including by taking title to patents where disclosures should have been made. (Text of letter below, and PDF version here).

KEI will also send a letter to BARDA. The letter below was addressed to DOD and DARPA, and focuses on their funding.

Context

The obligation to disclose federal funding in patent applications has been subject to presidential executive orders, statutes, regulations and contracts, including those cited and quoted in Abinader’s report. The disclosure clarifies the public’s rights in the inventions and the obligations on the entity getting the money, on everything from the government’s worldwide royalty free license to the public’s march-in rights, obligations to make inventions available to the public on reasonable terms, and additional safeguards that can be exercised by a government inclined to do so.

Secondly, the disclosure changes the narrative about who has financed the inventive activity, often the most risky part of development.

One of the earlier norms on this was Franklin Roosevelt’s Executive Order 9424, on the Establishment of a Register of Government interests in patents.

In 2018, the regulations on disclosure were modified by NIST (see 83 FR 15954), where, among other things, the government gave itself unlimited time to remedy a failure to disclose federal funding, to eliminate one loophole that created an incentive ignore the disclosure requirement.

In the past, the US Department of Defense has taken title to patents where federal funding was not disclosed. See: Campbell Plastics v. Brownlee, 389 F.3d 1243 (Fed. Cir. 2004).

There is more on the broader issue of disclosure of government funding in patents here: https://www.keionline.org/bayh-dole/failure-to-disclose

The research on the Moderna/DARPA funding is outlined in a 25 page August 27, 2020 report by Luis Gil Abinader, titled: “Moderna failures to disclose DARPA funding in patented inventions.” RN-2020-3

Below is the text of the KEI letter to Dr. Mark T. Esper, Secretary of Defense, and Dr. Amy Jenkins, of the Pandemic Prevention Platform for the Defense Advanced Research Projects Agency (DARPA), regarding the apparent failure by Moderna to disclose DARPA funding in patent applications.
PDF copy here:

2020. September 18. DARPA letter to KEI confirming investigation of Moderna for failure to report government funding in patent applications. https://www.keionline.org/33970

2020. September 4. BARDA is investigating Moderna’s failures to disclose BARDA funding in patent applications. https://www.keionline.org/33907

2020. September 2. KEI request to BARDA concerning Moderna obligations to disclose federal funding in patent applications. https://www.keionline.org/33892

2020. August 30. DARPA announces investigation into Moderna’s apparent failures to disclose mRNA vaccine patents. https://www.keionline.org/33832

2020. August 28. KEI asks DOD to investigate failure to disclose DARPA funding in Moderna patents. https://www.keionline.org/33763

2020. August 27. 2020:3 KEI Research Note: Moderna failures to disclose DARPA funding in patented inventions. https://www.keionline.org/rn-2020-3

2020. August 5. BARDA Responds to KEI, Public Citizen Letter Asking BARDA to Enforce Moderna Contract. https://www.keionline.org/33633

2020. August 4. KEI and Public Citizen request BARDA to address Moderna’s noncompliance with COVID-19 vaccine contract term. https://www.keionline.org/33618

2020. July 1. KEI receives seven new contracts for COVID 19 research from BARDA and DOD, including five using “Other Transactions Authority” that weaken or eliminate Bayh-Dole and FAR Safeguards. https://www.keionline.org/covid19-ota-contracts

2020. May 21. Moderna and US Government Funding of its COVID-19 Vaccine Candidate. https://www.keionline.org/33150

MORE Press Coverage

Washington Post
2020. August 28. “Moderna failed to disclose federal support in vaccine patents, researchers say: The company with a leading coronavirus vaccine candidate did not adhere to a law designed to protect public investment.” Washington Post. Christopher Rowland.
https://www.washingtonpost.com/business/2020/08/28/moderna-vaccine-patents-darpa-funding/

Bloomberg
2020. August 29. “Moderna’s Patents Probed by U.S. Defense Department, FT Says.” Bloomberg. Chiara Vasarri. https://www.bloomberg.com/news/articles/2020-08-29/u-s-government-s-darpa-probes-patents-filed-by-moderna-ft

Axios
2020. August 5. “Moderna skirts disclosures of coronavirus vaccine costs.” Axios. Bob Herman. https://www.axios.com/moderna-barda-coronavirus-funding-disclosure-2775a517-a775-485a-a509-b6906c8535a9.html

STAT
2020. September 4. “A second U.S. agency will review if Moderna disclosed federal funding in vaccine patents.” STAT. Ed Silverman. https://www.statnews.com/pharmalot/2020/09/04/moderna-vaccine-darpa-barda-patents-covid19/

2020. August 8. “Moderna failed to disclose federal funding for vaccine patent applications, advocates say.” STAT. Ed Silverman. https://www.statnews.com/pharmalot/2020/08/28/moderna-covid19-vaccine-coronavirus-patents-darpa/

2020. August 4. “BARDA faces pressure to force Moderna to disclose cost details from its Covid-19 contract.” Ed Silverman. https://www.statnews.com/pharmalot/2020/08/04/covid19-coronavirus-pandemic-barda-moderna-vaccine-transparency/

Financial Times
2020. August 29. “US government’s Darpa probes Moderna’s vaccine patents: Researchers accuse biotech company of failing to disclose federal grants in patents which also cover Covid-19 candidate.” Financial Times. Donato Paolo Mancini. https://www.ft.com/content/2be1f87e-9e96-4e23-9cc5-33ba35e50586

National Public Radio (NPR)
2020. August 4. “Prices For COVID-19 Vaccines Are Starting To Come Into Focus.” NPR. Sydney Lupkin. https://www.statnews.com/pharmalot/2020/08/04/covid19-coronavirus-pandemic-barda-moderna-vaccine-transparency/

Health Policy Watch
2020. September 3. “US Biomedical Advanced Research & Development Agency Reviews Moderna’s US Patents For Alleged Failure To Disclose Federal Funding.” Health Policy Watch. Grace Ren.
https://healthpolicy-watch.news/pharma-watchdog-requests-further-inquiries-into-modernas-us-patents/

2020. September 1. “US Department Of Defense Is Investigating Moderna’s Patents For Allegedly Failing To Disclose Federal Support.” Health Policy Watch. Grace Ren. https://healthpolicy-watch.news/usagency-investigating-moderna-for-allegedly/

The Pharma Letter
2020. September 4. “Non-profit says Moderna hid federal funding from patent office.” The Pharma Letter. https://www.thepharmaletter.com/article/nonprofit-says-moderna-hid-federal-funding-from-patent-office

Life Sciences Intellectual Property Review
2020. September 8. “Moderna’s COVID-19 and Zika patent applications to be investigated.” Life Sciences Intellectual Property Review. Muireann Bolger. https://www.lifesciencesipreview.com/news/moderna-s-covid-19-and-zika-patent-applications-to-be-investigated-4183

Law360
2020. September 4. “HHS Unit Probes Funding For Moderna’s Patented Vaccines.” Law360. Kevin Stawicki. https://www.law360.com/articles/1307690/hhs-unit-probes-funding-for-moderna-s-patented-vaccines

2020. August 31. “DOD Investigating Moderna’s Vaccine Patents.” Law360. Kevin Stawicki. https://www.law360.com/compliance/articles/1305849/dod-investigating-moderna-s-vaccine-patents

2020. August 28. “Activists Say Moderna Hid Gov’t Support For Vaccine Patents.” Law360. Kevin Stawicki. https://www.law360.com/articles/1305474

Moderna’s vaccine was developed with support from the NIAID, and, as covered in a past fact check, analysis from Axios found that the National Institutes of Health, of which the NIAID is part, may own intellectual property used in producing Moderna’s vaccine. Dr. Francis Collins, director of NIH, has also said that NIH has a stake in intellectual property used in the vaccine, though what exactly this means in practical terms is unclear. 

The Dispatch Fact-check

Also…

All the documents Glenn Beck is creaming about and more can be found below:

Nipah virus as in…?

READ: URGENT! DEBUNKING THE NEXT ENGINEERED PANDEMIC: HEMORRHAGIC FEVER (NIPAH, MARBURG, EBOLA)

Well, yeah, no coincidence here either, more proof to that below.

SO WE HAVE A FINACIER WHO TOOK OVER A WELL FUNDED PHARMA START-UP AND BROUGHT IN HUGE FUNDS, IGNITING THE MOTHER OF ALL ENRONS. WHO’S THIS GUY?!

Buckle up, friends, this so far was jus the prelude.

Bancel came to Moderna from the French Merieux Institute.

Merieux happens to be the French billionaire who helped China build the infamous P4 Lab in Wuhan.

Merieux also happens to be an old friend of Xi’s.

That Xi visit at the Merieux HQ in France happened in 2014, not long after this:

Obama & Xi working together on a pandemic playbook in 2012

And then, in 2018..

2017

Bancel maintained a top role in the Merieux Foundation long after leaving the BioMerieux division for Moderna.

CA Merieux Foundation

Therefore no surprise that Moderna was allegedly the first to get the SARS-COV2 genetic code and start working on the mRNA injection.

CONFIDENTIAL DOCUMENTS: MODERNA SENT A MRNA CORONAVIRUS VACCINE CANDIDATE TO UNIVERSITIES WEEKS BEFORE EMERGENCE OF COVID-19

MORE COINCIDENCE THEORIES

In 2017, Moncef Slaoui, the brain behind GSK, also took a seat on the board of Moderna,

Trump awarded Moderna almost $0.5Billion from public money a few days before nominating Slaoui as Warp Speed co-chief. in May 2020.

Trump’s Moroccan “vaccine czar”: worked for Bill Gates, Google, GSK. Worked in China. Transhumanist. Lockdown fanatic

“Valera’s efforts (Moderna subsidiary) have resulted in the demonstration of preclinical efficacy of Moderna’s mRNA-based vaccines in multiple viral disease models, Moderna said.

In the partnership with the Gates Foundation, Valera will apply its mRNA vaccine platform as well as Moderna’s drug platform Messenger RNA Therapeutics™. Designed to produces human proteins, antibodies, and entirely novel protein constructs inside patient cells, the therapeutics are secreted or active intracellularly.” – Genetic Engineering & Biotechnology News

To avoid a conflict of interest, Slaoui resigned from the board of the Massachusetts-based biotech firm Moderna, which had been developing a vaccine for the coronavirus.
He stepped down but he didn’t give up his stakes in Moderna, as the Daily Beast reports:

“Slaoui’s ownership of 156,000 Moderna stock options, disclosed in required federal financial filings, sparked concerns about a conflict of interest.
Democratic Massachusetts Senator Elizabeth Warren called Slaoui out over the matter on Twitter: “It is a huge conflict of interest for the White House’s new vaccine czar to own $10 million of stock in a company receiving government funding to develop a COVID-19 vaccine. Dr. Slaoui should divest immediately.”
The company’s shares skyrocketed last month after news broke of the $483 million in federal funding to work on a coronavirus vaccine.
Slaoui could not immediately be reached for comment on the matter.”

Slaoui also sits on the boards of SutroVax, the Biotechnology Innovation Organization, the International AIDS Vaccine Initiative, and the PhRMA Foundation

Gates, Fauci and Slaoui have long been making and selling scandalous vaccines together. It’s a cartel

So we should add Bancel to this cover graphic
DAVOS 2022: BANCEL AND FAUCI MEET AGAIN TO WHINE ABOUT THE ANNOYANCE WE ARE TO THEM. MORE TO COME, SCUMBAGS!

LAST MINUTE:

The circle has just closed.
Unless China faked another interview to prop up another myth.

So this has never been about health, just a global scale racketeering operation that’s coming to light about about to go bust. You can speed up this process simply by spreading this expose far and wide!

UPDATE MARCH 21, 2022: VOILA!

Via our ex-BlackRock friend Edward Dowd. I rest my case, but I bet they will “unrest” it soon.

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

ORDER

UPDATE: LATER JOSH ROGIN APPEARANCE ON JOE ROGAN’S PODCAST

Washington Post’s Josh Rogin Calls Out Media for Ignoring Fauci’s Potential Connection to Wuhan Lab

Rudy Takala  April 25, 2021


Washington Post columnist Josh Rogin lamented the media’s refusal to discuss aspects of the Covid-19 pandemic, including Dr. Anthony Fauci’s potential connection to a Wuhan lab, in an interview with Megyn Kelly.

a man wearing a suit and tie: Anthony Fauci Tasos Katopodis/Getty Images© Provided by Mediaite Anthony Fauci Tasos Katopodis/Getty Images

“This body of research, this gain-of-function research, the whole world of virologists … it’s very insular,” Rogin said in an interview on Kelly’s podcast. “I often talk to scientists who say the same thing, who say, ‘Listen, we really want to speak out about this, but we can’t do it.’ Why can’t we do it? Well, We get all of our funding from NIH, or NIAID, which is run by Dr. Fauci. … And so we can’t say anything like ‘Oh, gain-of-function research might be dangerous, or it might have come from a lab, because we’re going to lose our careers, we’re going to lose our funding, we’re not going to be able to do our work.’

“Gain-of-function” research focuses on artificially enhancing the transmissibility of pathogens. In the five years prior to the coronavirus pandemic, that research was spearheaded in China by the Wuhan Institute of Virology. The U.S. National Institute of Allergy and Infectious Diseases, which Fauci has led since 1984, oversees funding for most of the related research in America. The agency falls under the National Institutes of Health, which Rogin referenced.

“The head of the funding, the head of the entire field, really, is Anthony Fauci,” Rogin said. “He’s the godfather of gain-of-function research as we know it. That, what I said right there, is too hot for TV, because people don’t want to think about the fact that our hero of the pandemic … might also have been connected to this research, which might also have been connected to the outbreak.

“The problem is not that they were doing something wrong or illegal,” he noted. “The problem is that nobody knows what this legal stuff was that was going on. And now, all of a sudden, we have to take a look at it.”

Fauci has inspired critics in some quarters for his role in approving a $3.7 million grant to the Wuhan lab in 2015 to engage in related research, which came just a year after the Obama administration issued a moratorium on conducting such research in the U.S.

Rogin claimed in a book published last month that sources informed him China engaged in that research more aggressively than was previously understood, arguing that it contributed to evidence the Covid-19 pandemic stemmed from the lab in Wuhan.

“The Wuhan Institute of Virology had openly participated in gain-of-function research in partnership with U.S. universities and institutions,” Rogin noted in the book. “But [an] official told me the U.S. government had evidence that Chinese labs were performing gain-of-function research on a much larger scale than was publicly disclosed, meaning they were taking more risks in more labs than anyone outside China was aware of. This insight, in turn, fed into the lab-accident hypothesis in a new and troubling way.”

Rogin expanded on that statement in his interview with Kelly, saying, “Dr. Fauci, the hero of the pandemic, might also have had a role in the research that may have caused the pandemic.”

“People can’t get it through their heads, but that’s the reality,” he added, before lamenting that the topic was largely absent from public dialogue. “We don’t have a media environment where we can have that kind of discussion.”

Listen above via The Megyn Kelly Show.
The post Washington Post’s Josh Rogin Calls Out Media for Ignoring Fauci’s Potential Connection to Wuhan Lab first appeared on Mediaite, but we picked it up from Microsoft News.

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

This is a corroboration of a few recent reports from various news outlets in India and external sources. We face another grave under-reported fact in a “top-shelf authoritative source” CV. Or CR. The ramifications are vast.
We have much more of these to disclose in the near future.

<< India has asked the American frontline public health agency, the Centre for Disease Control and Prevention (CDC) to stop funding virus research studies in the country. CDC was caught funding Karnataka’s Manipal Center for Virus Research (MCVR) for secretly carrying out research on the lethal Nipah virus – a pathogen considered potential bioweapon. The fact that an under-qualified private laboratory was secretly handling a dangerous virus under government’s nose at the behest of a foreign agency has raised major concerns within the health ministry apparatus.

The matter is more complicated with the fact that the CDC has a checkered history in India. The Indian defense establishment believes that the CDC was involved in the plague outbreak in the western Indian city of Surat in 1994, which they consider to be a case of bioterrorism. Earlier in February this year the Indian government launched an investigation into another secret research being conducted on bat hunters in the eastern Indian state of Nagaland, funded by the US Department of Defense in collaboration with Wuhan Institute of Virology and the Bill and Melinda Gates Foundation.

CDC put on Watchlist

A $3.6 million donation from Atlanta-based US health agency CDC to Indian research agencies for tackling the COVID-19 pandemic has been put on hold by the Ministry of Home Affairs (MHA). The CDC has been placed on the watchlist since December 2019 for its involvement in funding virus research without government’s approval.

The Nipah research fiasco that came into light in October last year was the primary reason behind the MHA decision. As of now, any funding or donation from the U.S government body CDC would be first cleared by the MHA itself. They can no longer send funds directly to any government or private institution in India without MHA’s clearance.

No translation availables, sorry!

CDC secretly funds risky virus research in India

In October 2019, Hindustan Times reported that the Union health ministry wrote to both CDC and Manipal Center for Virus Research, ordering them to shut down the study related to Nipah virus that belongs to Risk Group 4 (RG4) classification. The RG4 viruses are considered highly dangerous and have no treatment or vaccine. They can only be tested in BSL4 lab which is the highest level of biological safety. The health ministry was upset that a study related to high risk pathogens like Nipah was being carried out at MCVR which is BSL2+ level facility.

A memorandum sent out by the health ministry said:

“It has been brought to our notice that CDC had trained MCVR for diagnosis of Nipah virus disease (NIV) in spite of the known fact that NIV is BSL 4 level pathogen whereas MCVR is a level BSL2+lab. Prior to this training to MCVR, CDC has not consulted national/govt agencies as per norm. Since Nipah is a high risk pathogen with potential for being used as agent of bio-terrorism the samples were to be handled more carefully and tested only in a BSL4.”

While CDC admitted that the training program didn’t have the necessary approval due to some confusion, it maintained that they did not commission the research directly. “The training was done through the Global Health Security Agenda (GHSA) and was aimed at strengthening laboratory systems in India which allowed for detection of Nipah virus.”

Manipal Center of Virus Research collaboration with US CDC
International collaborations of Manipal Center of Virus Research

CDC has partnered with MCVR to carry out illness surveillance across India under the project known as AFI surveillance which tracks mysterious diseases in the government hospitals. The Indian government has now asked both agencies to stop the surveillance project. It also warned CDC to ensure all funding is approved by the government.

In its defence, MCVR denied carrying out any risky virus isolation work at their lab. Dr. Arunkumar, Director of MCVR, said:

“We did not take approval from HMSC. Prior to testing, MCVR inactivated the virus. Inactivation of the virus was carried out in BSL3 facility at MCVR. Once inactivated, the virus cannot spread. Molecular testing was carried at MCVR in its BSL2 facility. No Nipah virus sample was transferred from MCVR to any other lab (except NIV Pune) within and outside the country.”

Investigation on secret research on Bat Hunters

This is not the first time a dangerous research took place in India without keeping the government in loop. Back in February this year, the officials confirmed to that foreign funded researchers were conducting study on bats and bat hunters (humans) in the northeastern state of Nagaland. Bats are known to often carry viruses such as ebola, SARS coronavirus, rabies,etc.

What’s more alarming was that two of the 12 researchers belonged to the Wuhan Institute of Virology’s Department of Emerging Infectious Diseases – the same institute from where COVID-19 outbreak is believed to have originated. The Nagaland study was funded by the United States Department of Defense’s Defense Threat Reduction agency (DTRA).

The results of the study were published in October last year in the PLOS Neglected Tropical Diseases journal, originally established by the Bill and Melinda Gates Foundation.

To conduct a high-risk study in India, they would have needed special permissions from the Indian authorities which was not sought by the parties involved in the study. The fact that scientists from foreign countries were allowed to handle live samples of bats and bat hunters without permission prompted Indian Council of Medical Research (ICMR) to send a five-member committee to investigate the matter.

Funding of controversial Gain-of-Function research

Even before the coronavirus outbreak, a number of controversial studies were being carried out at China’s Wuhan lab under the patronage of United States’ National Institutes of Health (NIH). One of the studies is the gain-of-function research on bat coronaviruses which involves mutating viruses in the lab to explore their potential for infecting humans.

The gain-of-function research has been widely criticized by the scientists around the world due to the risk of starting a pandemic from accidental release.

However, last year the National Institute for Allergy and Infectious Diseases, the organization led by Dr. Anthony Fauci, funded scientists at the Wuhan Institute of Virology and other institutions for work on gain-of-function research. A total of $7.5 million of American tax dollars have been spent since 2014 for conducting GoF studies.

Role of CDC in Surat plague

The plague outbreak in the western Indian city of Surat in 1994 has been mired in controversy just as COVID-19. Around 55 people died and close to a half of the city of 1.2 million people fled Surat for fear of the plague and of being quarantined.

The origin of the outbreak is still a mystery. Indian defense establishment believes the 1994 Surat Plague is a case of bioterrorism. Numerous media outlets at the time reported the involvement of American CDC. It was suspected that the germ with an extra protein ring was developed by a CDC lab in Almaty, Kazakhstan.

Thus it comes as no surprise that Indian authorities are taking no chances this time around with CDC, especially since the world is already under the grip of a virus pandemic and the role of CDC is increasingly being seen as suspicious. >> GGI

Additionally, The Week Magazine from India reported recently:

<< Did the novel coronavirus leak similarly through a worker in a biowar lab in Wuhan? The Washington Times, which is known for its CIA links, has raised the suspicion in an article quoting Dany Shoham, a former Israeli military intelligence officer who has studied Chinese biowarfare.

Indian scientists would not rule out the possibility. The Wuhan lab, said Dr William Selvamurthy, a former chief controller of the Defence Research and Development Organisation who was in charge of the life science labs, could have been keeping the virus under BSL-4 (biosafety level-4)—the most secure condition for reseach. So, the possibility of someone having been infected from the lab and inadvertently spreading it could not be ruled out, said Selvamurthy.

The Wuhan Institute is officially acknowledged to be China’s most advanced virus research lab complex. China, a signatory to the Biological Weapons Convention (BWC) since 1985, had, in 1993, declared the Wuhan Institute of Biological Products as one of eight biowarfare research facilities covered by the BWC. Yet, last year’s US state department report on arms control compliance had accused China of working on military pathogens for offensive purposes. It said the US had concerns with respect to “Chinese military medical institutions’ toxin research and development because of the potential dual-use applications and their potential as a biological threat”.

China has maintained that the virus has originated from wild animals sold at a market in Wuhan. The lab under suspicion is just about 30km from the market. The virus has been identified as a virulent strain, much like any classical germ warfare strain—they were designed to be virulent initially, but quickly controllable. The idea, as a military scientist explained, was for the germ to be released in hostile territory to disable the enemy, but the territory would have to be quickly sanitised for your own forces to capture it.

During the 1994 plague outbreak in Surat and Beed, it was found that the germs had an extra protein ring which could only have been inserted artificially. Indian scientists had raised concerns about a US biowar experiment having gone awry. THE WEEK had carried reports giving details of germ war research being carried on in labs under the Centre for Disease Control in Atlanta and about a newly developed germ detector being tested. The US embassy had denied the allegations. There were also reports that the Surat germ could have been developed in a lab in Almaty, Kazakhstan.

There have been rumours and reports in Chinese cybermedia in the last few days suggesting that the Wuhan outbreak could have been a US biowar attack. This, US officials consider, was an attempt to preempt charges that the new virus had escaped from the Wuhan lab, which had been in the crosshairs of the west especially after a team of Chinese virologists working in a lab in Winnipeg, Canada, unauthorisedly sent samples of some of the deadliest viruses on earth to China.” >> – The Week Mag

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Whatever happened to Rule #0 in true journalism: “verify every statement from three or more independent sources”?! Mainstream media is just commentary and unverified press releases. This research below gets as close to the requirements as it can in this heavily censored and gate-kept environment. But it also aligns with everything we’ve already published on this matter (quite a lot) unlike Fauci’s words align with each other.
You may have heard already some of this news as it goes viral, but it’s our original combo that puts to rest the entire official pandemic narrative.

Judicial Watch has just uncovered correspondences from Dr. Anthony Fauci outlining his focus on being in compliance with the Chinese Communist Party and their demands on the USA for COVID restrictions. And two more bombshells align.

“These new emails show WHO and Fauci’s NIH special accommodations to Chinese communist efforts to control information about COVID-19,” said Judicial Watch President Tom Fitton.

From the press release Judicial Watch has put out on Monday :

Judicial Watch announced today that it and the Daily Caller News Foundation (DCNF) received 301 pages of emails and other records of Dr. Anthony Fauci and Dr. H. Clifford Lane from the U.S. Department of Health and Human Services showing that National Institutes of Health (NIH) officials tailored confidentiality forms to China’s terms and that the World Health Organization (WHO) conducted an unreleased, “strictly confidential” COVID-19 epidemiological analysis in January 2020.

Additionally, the emails reveal an independent journalist in China pointing out the inconsistent COVID numbers in China to NIH’s National Institute of Allergy and Infectious Diseases’ Deputy Director for Clinical Research and Special Projects Cliff Lane.

The emails were obtained in response to a Freedom of Information Act (FOIA) lawsuit filed in the U.S. District Court for the District of Columbia by Judicial Watch on behalf of the DCNF (Daily Caller News Foundation v. U.S. Department of Health and Human Services(No. 1:20-cv-01149)).

The lawsuit was filed after HHS failed to respond to the DCNF’s April 1, 2020, FOIA request seeking:

  • Communications between Dr. Fauci and Deputy Director Lane and World Health Organization officials concerning the novel coronavirus.
  • Communications of Dr. Fauci and Deputy Director Lane concerning WHO, WHO official Bruce Aylward, WHO Director General Tedros Anhanom, and China.

The new emails include a conversation about confidentiality forms on February 14-15, 2020, between Lane and WHO Technical Officer Mansuk Daniel Han. Han writes: “The forms this time are tailored to China’s terms so we cannot use the ones from before.”

A WHO briefing package sent on February 13, 2020, to NIH officials traveling to China as part of the COVID response ask that the officials wait to share information until they have an agreement with China: “IMPORTANT: Please treat this as sensitive and not for public communications until we have agreed communications with China.”  

In an email dated January 20, 2020, a WHO official discusses the epidemiological analysis they conducted of COVID-19 earlier that month and states that it is “strictly confidential,” is “only for,” the Strategic and Technical Advisory Group for Infection Hazards (STAG-IH), and “should not be further disseminated.”

In an email dated March 4, 2020, from Chinese journalist Zeng Jia to Lane, a reporter for Caixin Media, points out to Fauci deputy Cliff Lane that the number of cases reported in the WHO Joint China Mission’s report are inconsistent with the number reported by the Wuhan Public Health Committee:

It says on Page 6 [in the WHO report] that there was at least one clinically diagnosed case of coronavirus on December 2th, 2019, in Wuhan; and from Jan 11th to 17th there were new clinically diagnosed and confirmed cases every day in Wuhan, which is not consistent with Wuhan Public Health Committee’s numbers.

In an email dated February 15, 2020, Gauden Galea, head of the WHO office in China, informs the joint mission members traveling to China that all of their activities in China would be arranged by the Chinese Government’s National Health Commission.

“These emails set the tone early on in the coronavirus outbreak. It’s clear that the WHO allowed China to control the information flow from the start. True transparency is crucial,” said Ethan Barton, editor-in chief for the Daily Caller News Foundation.  

“These new emails show WHO and Fauci’s NIH special accommodations to Chinese communist efforts to control information about COVID-19,” said Judicial Watch President Tom Fitton.

This is the latest information obtained in Judicial Watch and the DCNF’s ongoing investigation into Fauci’s and NIH’s response to the coronavirus pandemic. Judicial Watch and the DCNF previously uncovered emails showing a WHO entity pushing for a press release, approved by Dr. Fauci, “especially” supporting China’s COVID-19 response.  

And this comes just 10 days after Taiwan News unearthed another bombshell we’ve just learned about:

TAIPEI (Taiwan News, 2021/01/18 00:31) — Video taken just days before the start of the coronavirus pandemic shows a current World Health Organization (WHO) inspector discuss the testing of modified coronaviruses on human cells and humanized mice in the Wuhan Institute of Virology (WIV), just weeks before the first cases of COVID-19 were announced in the city of Wuhan itself.

In a video that was originally taken on Dec. 9, 2019, three weeks before the Wuhan Municipal Health Commission announced an outbreak of a new form of pneumonia, virologist Vincent Racaniello interviewed British zoologist and president of EcoHealth Alliance Peter Daszak about his work at the nonprofit to protect the world from the emergence of new diseases and predict pandemics. Since 2014, Daszak’s organization has received millions of dollars of funding from the U.S. National Institutes of Health (NIH), which it has funneled to the WIV to carry out research on bat coronaviruses.

In the first phase of research, which took place from 2014 to 2019, Daszak coordinated with Shi Zhengli, (石正麗), also known as “Bat Woman,” at the WIV on investigating and cataloging bat coronaviruses across China. EcoHealth Alliance received US$3.7 million in funding from the NIH for this research and 10 percent was channeled to the WIV, reported NPR.

The second, more dangerous phase, which started in 2019, involved gain-of-function (GoF) research on coronaviruses and chimeras in humanized mice from the lab of Ralph S. Baric of the University of North Carolina. Funding for the program was withdrawn by the NIH under the Trump administration on April 27 amid the pandemic.

At the 28:10 mark of the podcast interview, Daszak states that researchers found that SARS likely originated from bats and then set out to find more SARS-related coronaviruses, eventually finding over 100. He observed that some coronaviruses can “get into human cells in the lab,” and others can cause SARS disease in “humanized mouse models.”

He ominously warned that such coronaviruses are “untreatable with therapeutic monoclonals [antibodies] and you can’t vaccinate against them with a vaccine.” Ironically, he claims that his team’s goal was trying to find the next “spillover event” that could cause the next pandemic, mere weeks before cases of COVID-19 were beginning to be reported in Wuhan.

When Racaniello asks what can be done to deal with coronavirus given that there is no vaccine or therapeutic for them, Daszak at the 29:54 mark appears to reveal that the goal of the GoF experiments was to develop a pan-coronavirus vaccine for many different types of coronaviruses.

Based on his response, it is evident that just before the start of the pandemic, the WIV was modifying coronaviruses in the lab. “You can manipulate them in the lab pretty easily.” What he then mentioned has become the telltale trait of SARS-CoV-2, its spike protein: “Spike protein drives a lot of what happens with the coronavirus, zoonotic risk.”

Daszak mentions the WIV’s collaboration with Baric: “and we work with Ralph Baric at UNC [University of North Carolina] to do this.” As has been suggested by proponents that SARS-CoV-2 is a chimera made in a lab, he speaks of inserting the spike protein “into a backbone of another virus” and then doing “some work in the lab.”

Providing evidence of the creation of chimeras for the sake of a vaccine, he states “Now, the logical progression for vaccines is, if you are going to develop a vaccine for SARS, people are going to use pandemic SARS, but let’s try to insert these other related diseases and get a better vaccine.”

Based on Daszak’s statements, it appears that just before the start of the pandemic, the WIV was using GoF experiments with chimeras in an attempt to create a vaccine. These experiments appeared to have included infecting mice genetically modified to express the human ACE2 protein with these chimeras.

In a presentation titled “Assessing Coronavirus Threats,” which was delivered four years before the pandemic in 2015, Daszak points out that experiments involving humanized mice have the highest degree of risk. Demonstrating his close ties with the WIV, he also listed the lab as a collaborator at the end of the presentation. – Taiwan News

WHO inspector caught on camera revealing coronavirus manipulation in Wuhan before pandemic
(Assessing Coronavirus threats, Peter Daszak image)

Controversially, Daszak has been included among a team of experts from the WHO that has finally been allowed by Beijing to investigate the origin of the outbreak of COVID-19, over a year after it started. Scientists such as Richard Ebright, a molecular biologist at Rutgers University in New Jersey, are condemning Daszak’s participation due to conflicts of interest “that unequivocally disqualify him from being part of an investigation of the origins of the Covid-19 pandemic,” reported the Daily Mail.

“Peter Daszak’s organisation channelled cash to Wuhan scientists at the centre of growing concerns over a cover-up – and also collaborated on the sort of cutting-edge experiments on coronaviruses banned for several years in the United States for fear of sparking a pandemic.

The Wuhan Institute of Virology has been carrying out this risky research on bat viruses since 2015, including the collection of new coronaviruses and hugely controversial ‘gain of function’ experiments that increase their ability to infect humans.Peter Daszak¿s organisation channelled cash to Wuhan scientists at the centre of growing concerns over a cover-up

Peter Daszak’s organisation channelled cash to Wuhan scientists at the centre of growing concerns over a cover-up

Many leading scientists argue that deliberately creating new and infectious microbes poses a huge danger of starting a pandemic from an accidental release, especially as leaks from laboratories have often occurred.

Despite his close ties to the Wuhan Institute of Virology – and the way he has orchestrated efforts to stifle claims that the pandemic might not have happened naturally – Dr Daszak was invited by the World Health Organisation to join its team of ten international experts investigating the outbreak.

The prominent scientist, who runs a conservation charity originally founded by the famous naturalist and best-selling author Gerald Durrell, is also leading an investigatory panel on the pandemic’s origins set up by The Lancet medical journal

‘Peter Daszak has conflicts of interest that unequivocally disqualify him from being part of an investigation of the origins of the Covid-19 pandemic,’ said Richard Ebright, bio-security expert and professor of chemical biology at Rutgers University in New Jersey.

‘He was the contractor responsible for funding of high-risk research on Sars-related bat coronaviruses at Wuhan Institute of Virology and a collaborator on this research.’

Daszak, president of EcoHealth Alliance, has seen his career take him from researching rare land snails at Kingston University to his new key role investigating the eruption of the most destructive pandemic for a century.

SOURCE

The pugnacious scientist, originally from Manchester, spent much of the past year trying to counter claims of a possible laboratory leak while defending his friend Shi Zhengli, the Wuhan scientist known as Batwoman for her virus-hunting trips in caves.

‘Ignore the conspiracy theories: scientists know Covid-19 wasn’t created in a lab,’ ran the headline to one typical article he wrote in The Guardian.

But other scientists say there is no firm evidence at this stage to back Daszak’s insistence that Covid-19 crossed from animals to humans via natural transmission. Many point to the simple yet startling coincidence that Wuhan is home to Asia’s main research centre on bat coronaviruses as well as the place where the pandemic erupted.

Emails released through freedom of information requests have shown Daszak recruited some of the world’s top scientists to counter claims of a possible lab leak with publication of a landmark collective letter to The Lancet early last year. He drafted their statement attacking ‘conspiracy theories suggesting that Covid-19 does not have a natural origin’ and then persuaded 26 other prominent scientists to back it. He suggested the letter should not be identifiable as ‘coming from any one organisation or person’.

The signatories include six of the 12-strong Lancet team investigating the cause of the outbreak.

Yet it has emerged that Daszak had previously issued warnings over the dangers of sparking a global pandemic from a laboratory incident – and said the risks were greater with the sort of virus manipulation research being carried out in Wuhan.

In October 2015, he co-authored an article in the journal Nature on ‘spillover and pandemic properties of viruses’ that identified the risk from ‘virus exposure in laboratory settings’ and from ‘wild animals housed in laboratories’.

Seven months earlier, Daszak was a key speaker at a high-powered seminar on reducing risk from emerging infectious diseases hosted by the prestigious National Academies of Science in Washington. 

Among materials prepared for the meeting was a 13-page document by Daszak entitled ‘Assessing coronavirus threats’ that included a page examining ‘spillover potential’ from ‘genetic and experimental studies’.

This identified steps that increased dangers from such research – rising from lower risk sampling of viruses through to the highest risk from experiments on infecting isolated cells and on so-called ‘humanised mice’ – animals created for labs with human genes, cells or tissues in their bodies.

Yet on January 2 – three days after news broke outside China of a new respiratory disease in Wuhan – Daszak boasted on Twitter of isolating Sars coronaviruses ‘that bind to human cells in the lab’.

He added that other scientists have shown ‘some of these have pandemic potential, able to infect humanised mice’.

Another tweet two months earlier talked about ‘great progress’ with Sars-related coronaviruses from bats through identifying new strains, finding ones that bind to human cells and ‘using recombinant viruses/humanised mice to see Sars-like signs and showing some don’t respond to vaccines’.

Daszak also told a podcast that bat coronaviruses could be manipulated in a lab ‘pretty easily’, explaining how their spike proteins – which bind to human receptors in cells – drive the risk of transmission from animals to humans.” – Daily Mail

We gave up on our profit shares from masks, if you want to help us, please use the donation button!
We think frequent mask use, even short term use can be bad for you, but if you have no way around them, at least send a message of consciousness.
Get it here!

In light of the WHO’s trip to Wuhan, a researcher who goes by the pseudonym Billy Bostickson and his colleagues at DRASTIC (Decentralized Radical Autonomous Search Team Investigating COVID-19) have created a petition demanding that the international investigation team answer 50 key questions about the outbreak in Wuhan. Among the questions is a request to access to the facility’s database and laboratory records, which are supposed to go back 20 years and include a look at its safety procedures, safety audit reports, and safety incident reports.

And it gets even more explosive when we put all these in line with Daily Caller’s discovery that Daszak and his WHO commission boss have a long history of sucking China’s heels:

The chairman of a blue-ribbon commission working with the United Nations and the World Health Organization to investigate the origins of the coronavirus pandemic has a history of praising and working with China while criticizing the U.S. government.

Jeffrey Sachs, a Columbia economist, formed the Lancet COVID-19 Commission, affiliated with the prominent British medical journal of the same name, in July 2020 to investigate the virus’s origins.

Commission member Peter Daszak, a zoologist who is on the Lancet commission, served as the only American on a WHO team that recently visited Wuhan, China, to investigate the spread of the virus.

Daszak has been accused of having conflicts of interest due to millions of dollars of grants he has received from the U.S. government for research with the Wuhan Institute of Virology, which some U.S. officials have said may have been the initial, accidental source for the coronavirus.

Daszak, Sachs and the Chinese government have all vehemently disputed the so-called lab leak theory.

Also: Google has stakes in the Astrazeneca Covid jab

Sachs has also come under some scrutiny in the past for his praise of Chinese government initiatives and his appearances on China state-controlled media outlets criticizing the Trump administration.Does the COVID commission chief have a history of praising China?Yes No  Completing this poll entitles you to WND news updates free of charge. You may opt out at anytime. You also agree to our Privacy Policy and Terms of Use.

In June 2020, Sachs accused the U.S. government of “trying to create a new cold war” with China.

“The U.S. is a force for division, not for cooperation,” he told the BBC in a June 21, 2020, interview.

In December 2018, he called the U.S. government “today’s greatest threat to the international rule of law” and “global peace” after the U.S. asked Canada to arrest an executive with the Chinese tech firm Huawei.

And in an interview last month, Sachs deflected questions about China’s human rights abuses against Muslim Uighurs, saying that there are “huge human rights abuses committed by the U.S. on so many fronts.”

He also accused former Secretary of State Mike Pompeo of “stirring the pot to raise tensions” after the diplomat criticized Chinese authorities’ crackdown on pro-democracy protesters in Hong Kong.

The Lancet COVID-19 Commission has afforded Sachs access to both the United Nations and the WHO, both of which have been accused of appeasing the Chinese government amid fallout over Beijing’s early cover up of the severity of coronavirus.

The commission’s website says it partners with The Lancet, the prominent medical journal, and with the United Nations Sustainable Development Solutions Network, which was formed in 2012 by then-UN Secretary-General Ban Ki-Moon.

It is unclear what influence the Lancet commission has had on WHO and UN’s coronavirus related efforts, but Sachs co-hosted an online forum on Dec. 17 with the WHO to discuss Asian countries’ handling of the pandemic.

Sachs, who served as an adviser to the UN from 2002 to 2018, also met with the president of the United Nations General Assembly on Jan. 22 to discuss the Lancet commission’s work.

Sachs has also appeared on CNN to tout a study he co-authored at Columbia in October that estimated that then-President Donald Trump’s policies were responsible for between 130,000 and 210,000 additional COVID-19 deaths.

The Lancet commission claimed in its early statements that it would investigate all theories about the virus origins with an open mind, though remarks from Daszak and Sachs both suggest that they dismissed the lab leak theory long ago.

The commission listed 10 priorities for action in its initial statement on Sept. 14, 2020.

The top priority, the commission said, was to “Track down the origins of the virus in an open, scientific, and unbiased way not influenced by geopolitical agendas.”

Daszak, who leads the New York-based EcoHealth Alliance, said in a statement on Nov. 23 that the commission would conduct “a thorough and rigorous investigation” into the early spread of the virus.

But emails recently released by U.S. Right to Know, a health care watchdog group, show that Daszak organized a group of 27 scientists back in February 2020 to sign a letter published by The Lancet calling the accidental lab leak hypothesis a “conspiracy theory.”

U.S. Right to Know asserted that the emails show Daszak had made up his mind about the theory nearly a year before he joined the WHO team investigating the virus origins in China.

Daszak, along with many other scientists, have embraced the theory that the virus jumped from an animal species to humans, likely at a food market in Wuhan.

The watchdog group has also accused Daszak and the EcoHealth Alliance of having a conflict of interest because of grants the group has received from the U.S. government for work with the Wuhan lab.

Sachs also dismissed the lab leak theory before the Lancet commission had investigated the virus’s origins.

In a virtual discussion in September, Sachs called the lab leak hypothesis “an extremely dangerous point,” but said it was “important” to publicly dispute it.

Daszak has been one of the more vocal members of the 17-member WHO investigative team.

After State Department spokesman Ned Price said on Feb. 9 that the U.S. government planned to independently review the WHO team’s findings, Daszak shot back on Twitter, urging: “don’t rely too much on U.S. intel.”

The leader of the WHO team, Peter Ben Embarek, said last week that the theory that the virus was the result of an accidental lab leak from the Wuhan Institute of Virology was “extremely unlikely.”

The New York Times declared Embark’s remarks a “public relations win” for the Chinese government since officials there have long denied the lab leak hypothesis.

The WHO’s assessment has been met with wide skepticism, even within President Joe Biden’s administration, which has defended the WHO against conservative threats to defund it over its alleged appeasement of China.

Jake Sullivan, the Biden administration’s national security adviser, issued a statement Saturday saying the U.S. was “deeply concerned” by reports that Chinese authorities withheld raw data on early coronavirus cases from the WHO investigators.

Some scientists have cast doubt on the WHO’s findings, pointing to Daszak’s role on the team.

“I was not surprised at all about the conclusions of the WHO. Having Daszak on board and deciding to visit a few labs in Wuhan only after pressure from the media was not very promising,” Rossana Segreto, a researcher at the University of Innsbruck, told the Daily Caller.

While Sachs has no apparent financial ties to the Wuhan lab, he has for years been a reliable defender of China’s foreign and domestic policy. From 2001 to 2002, he advised China’s State Development Planning Commission, which sets the communist regime’s economic policies.

Sachs became a frequent guest of China’s state-controlled media outlets to voice criticism of Trump’s aggressive stance toward Beijing. The Washington Free Beacon reported some of his comments last year after progressive Democrats floated Sachs for a position in the Biden administration’s Treasury Department.

In an interview in April 2020 with CGTN, which the U.S. government considers a Chinese propaganda outlet, Sachs called Trump’s threat to cut funding to the WHO “disgusting” and “disgraceful.”

Trump had called for defunding the WHO based on allegations that it had failed to hold the Chinese government accountable for withholding data about the coronavirus.

Republicans accused WHO leaders of avoiding confrontation with China over the communist regime’s early handling of information about the coronavirus. In some cases, Beijing provided false information about the transmission of the virus and the number of cases detected in China.

On Jan. 14, 2020, the WHO cited Chinese authorities making the now-debunked claim that coronavirus was likely not infectious.

Sachs does not appear to have criticized the Chinese government over its bungled pandemic response.

Prior to the pandemic outbreak, Sachs contributed to a position paper released in November 2018 by Huawei, which manufactures surveillance equipment that the Chinese government has used to track Uighurs.

Sachs praised China’s poverty alleviation program during an interview with another state-controlled TV network.

“China has done more to reduce extreme poverty in a short period of time than any other country in history,” Sachs told the Beijing-controlled Xinhua News Agency in an interview that aired earlier this month.

The Chinese consulate in Australia tweeted out the video.

Sachs has also refused to condemn the Chinese government for engaging in intellectual property theft, and for human rights abuses against Uighurs in western China.

Instead, he accused the U.S. in an interview last month of engaging in similar human rights abuses and underhanded business tactics.

“It strikes me as odd that American policymakers think that the United States alone ought to run the show, or that the United States ought to gang up with other countries to corner China, as if this was the Cold War with the Soviet Union,” he said in an interview with The Wire China.

“Thereʼs no purity in this topic,” Sachs continued. “Thereʼs a lot of industrial espionage and cheating by U.S. companies.”

Sachs deflected questions about China’s human rights abuses against Uighurs, which Tony Blinken, the secretary of state under Biden, recently characterized as a “genocide.”

“We have huge human rights abuses committed by the U.S. on so many fronts,” Sachs said in the interview.

Sachs was on the advisory board to the China Energy Fund Committee, a think tank funded by CEFC China Energy, a now-defunct energy conglomerate affiliated with China’s People’s Liberation Army.

Sachs appeared at several events hosted by Patrick Ho, the chairman of the think tank.

During one event, Sachs praised China’s economic sustainability initiative, One Belt, One Road, at a China Energy Fund Event held in 2016.

“This plan is a pivotal one for China,” Sachs said at the event, according to China Daily.

Patrick Ho, the chairman of the think tank, was indicted and convicted on charges that he offered bribes on behalf of CEFC China Energy to two African leaders to purchase oil rights in their countries.

CEFC China paid Hunter Biden $6 million from August 2017, including $1 million to represent Ho.

Federal prosecutors obtained a Foreign Intelligence Surveillance Act (FISA) warrant on Ho based on the suspicion that he was working as a secret foreign agent, according to court filings in his case.

Sachs is also on the board of the Center for International Relations and Sustainable Development, a Serbian think tank founded by Vuk Jeremic, a former Serbian foreign minister who served as president of the UN General Assembly through 2012.

Jeremic testified at Ho’s trial that he made the introductions to the African officials who Ho tried to bribe.

Jeremic lobbied Hunter Biden to help him with his failed campaign for UN secretary-general in 2016, according to emails from Biden’s laptop.

The Lancet commission did not respond to questions about Sachs’ and Daszak’s past remarks, saying instead that the task force “will thoroughly and objectively review all publicly available evidence, and conduct interviews with key leaders in diverse fields.”

A spokesperson for the commission said that investigators “will carefully assess all leading hypotheses that have been raised about the origins of COVID-19, from a natural zoonotic event to a laboratory release.”

The commission plans to publish a final report in the Lancet.

Sachs did not respond to a detailed list of questions. – the Daily Caller News Foundation

As reported by GreatGameIndia last year, Chinese officials deleted 300 studies of Batwoman Shi Zhengli from the top secret Wuhan lab linked to the origins of COVID-19. Details of more than 300 studies, including many investigating diseases that pass from animals to humans are no longer available.

Last year a Beijing-based media group Caixin published a shocking report that the Hubei Provincial Health and Medical Commission ordered the destruction of Coronavirus samples.

Five years ago, Italian state owned media Company, Rai – Radiotelevisione Italiana, exposed these Chinese experiments on viruses.

The video, which was broadcast in November, 2015, showed how Chinese scientists were conducting biological experiments on a SARS connected virus believed to be Coronavirus, derived from bats and mice, asking whether it was worth the risk in order to be able to modify the virus for compatibility with human organisms.

The person who covered-up this biological experiments and orchestrated the myth of the natural origin of COVID-19 is Peter Daszak.

The President of EcoHealth Alliance, Peter Daszak is the one who orchestrated the myth that COVID-19 is natural in origin.

Emails obtained by U.S. Right to Know show that the statement in The Lancet authored by 27 prominent public health scientists condemning “conspiracy theories suggesting that COVID-19 does not have a natural origin” was organized by employees of EcoHealth Alliance.

I mean, correlation does not prove causation, but it proves correlation, and that’s bad enough. No way in hell can anyone claim the “autoritah” is telling the truth.

MORE RESOURCES:

NYT Daszak comes back from China: https://www.nytimes.com/2021/02/14/health/WHO-covid-daszak-china-virus.html

NIH Funding: https://reporter.nih.gov/project-details/8674931
2. https://reporter.nih.gov/project-details/9819304#details

Full Grant to EcoHealthAlliance: https://www.usaspending.gov/award/ASST_NON_R01AI110964_7529

Baric UNC Endeavors, Stalking Sars: http://endeavors.unc.edu/fall2003/baric.html

Baric Emails: https://usrtk.org/biohazards-blog/ralph-baric-emails/

Obama Guidance on Gain of Function: https://obamawhitehouse.archives.gov/blog/2017/01/09/recommended-policy-guidance-potential-pandemic-pathogen-care-and-oversight

GPMB thanking Resolve To Save Lives: https://apps.who.int/gpmb/assets/annual_report/GPMB_Annual_Report_English.pdf

Gain of Function is pointless and unsafe: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128689/

Justia Patent for whole coronavirus genome: https://patents.justia.com/patent/6593111

Nature: Sars-Like cluster of circulating bat coronaviruses shows potential for human emergence: https://www.nature.com/articles/nm.3985

Baric gets grant for research on emerging viruses: https://sph.unc.edu/sph-news/niaid-renews-5-year-grant-for-research-on-emerging-viruses

Science Mag: Risky Bird Flu gain of function research to resume (Feb 2019): https://www.sciencemag.org/news/2019/02/exclusive-controversial-experiments-make-bird-flu-more-risky-poised-resume

Also read:

BREAKING! CHINA ADMITS THE BIGGEST LIE, THE WEST AND BIG TECH COMPLICIT
trailer
EXCLUSIVE: GATES, FAUCI AND SLAOUI HAVE LONG BEEN COOKING AND SELLING SCANDALOUS VACCINES TOGETHER. IT’S A CARTEL
(1ST ANNIVERSARY SPECIAL) SOROS A ROTHSCHILD FRONTMAN, FORGED IMF-CHINA ALLIANCE. WE’RE LIVING THE CONSEQUENCES

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Sometimes my memes are 3D. And you can own them. Or send them to someone.
You can even eat some of them.
CLICK HERE

War is peace and truth is fake news in Covidiocray.
I hear there’s many more “fact-checks” on this, published by other presstitutes, that all seem copied from the same press-release or something…

First off: a New Scientist short article, as old as 2008, in verbatim copy, to take the bacteria debate out of the way

Bacteria were the real killers in 1918 flu pandemic

HEALTH 4 August 2008

By Ewen Callaway

New Scientist Default Image
(Image: US National Museum of Health and Medicine)

Medical and scientific experts now agree that bacteria, not influenza viruses, were the greatest cause of death during the 1918 flu pandemic.

Government efforts to gird for the next influenza pandemic – bird flu or otherwise – ought to take notice and stock up on antibiotics, says John Brundage, a medical microbiologist at the Armed Forces Health Surveillance Center in Silver Spring, Maryland.

Brundage’s team culled first-hand accounts, medical records and infection patterns from 1918 and 1919. Although a nasty strain of flu virus swept around the world, bacterial pneumonia that came on the heels of mostly mild cases of flu killed the majority of the 20 to 100 million victims of the so-called Spanish flu, they conclude.

“We agree completely that bacterial pneumonia played a major role in the mortality of the 1918 pandemic,” says Anthony Fauci, director of National Institute for Allergy and Infectious Disease in Bethesda, Maryland, and author of another journal article out next month that comes to a similar conclusion.

Double whammy

That pneumonia causes most deaths in an influenza outbreak is well known. Late 19th century physicians recognised pneumonia as the cause of death of most flu victims. While doctors limited fatalities in other 20th-century outbreaks with antibiotics such as penicillin, which was discovered in 1928, but did not see use in patients until 1942.

This is not to say that flu viruses do nothing, says Jonathan McCullers, an expert on influenza-bacteria co-infections at St Jude Children’s Research Hospital in Memphis, Tennessee.

McCullers’ research suggests that influenza kills cells in the respiratory tract, providing food and a home for invading bacteria. On top of this, an overstressed immune system makes it easier for the bacteria to get a foothold.

However, the sheer carnage of 1918 caused many microbiologists to reconsider the role of bacteria, and some pointed their fingers firmly at the virus.

‘Unique event’

When US government scientists resurrected the 1918 strain in 2005, the virus demolished cells grown in a Petri dish and felled mice by the dozen.

“The 1918 pandemic is considered to be – and clearly is – something unique, and it’s widely understood to be the most lethal natural event that has occurred in recent human history,” Brundage says.

But to reassess this conclusion, he and co-author Dennis Shanks, of the Australian Army Malaria Institute in Enoggera, Queensland, scoured literature and medical records from 1918 and 1919.

The more they investigated, the more bacteria emerged as the true killers, an idea now supported by most influenza experts.

For instance, had a super virus been responsible for most deaths, one might expect people to die fairly rapidly, or at least for most cases to follow a similar progression. However, Shanks and Brundage found that few people died within three days of showing symptoms, while most people lasted more than a week, some survived two – all hallmarks of pneumonia.

Local bugs

Military health records for barracks and battleships also painted a different picture. New recruits – men unlikely to have been exposed to resident bacteria – died in droves, while soldiers whose immune systems were accustomed to the local bugs survived.

And most compelling, Brundage says, medical experts of the day identified pneumonia as the cause of most deaths.

“The bottom line is we think the influenza virus itself was necessary – but not sufficient – to cause most of the deaths,” he says.

As the world’s health experts prepare for the next influenza pandemic, many have looked to 1918 as a guide, planning for a deadly super-virus.

The H5N1 bird flu strains jetting around the world seem to kill humans without the aid of bacteria, but those viruses aren’t fully adapted to humans, McCullers says. If H5N1 does adapt to humans, bacteria may play a larger role in deaths, he adds.

“Everyone is focused exclusively on the virus, and that’s probably not the best idea,” he says.

Antibiotics and vaccines against bacterial pneumonia could limit deaths in the next pandemic. And while an effective influenza vaccine should nip an outbreak in the bud, such a vaccine could take months to prepare and distribute.

“The idea of stockpiling [bacterial] vaccines and antibiotics is under serious consideration,” says Fauci, who is on a US government taskforce to prepare for the next flu pandemic.

At a recent summit on pandemic influenza, McCullers said health authorities were increasingly interested in the role bacteria might play, but there had been little action taken.

“There’s no preparation yet. They are just starting to get to the recognition stage,” he says. “There’s this collective amnesia about 1918.”

Journal reference: Emerging Infectious Disease (DOI: 10.3201/eid1408.071313)

and this is the fun part where reuters confirms everything in a desperate and hilarious debunk attempt

Ladies and gents, Facebook’s premium smear-machine aka “fact-checkers”, aka establishment’s mouth-pieces licensed to kill competition, aka world’s #1 news agency are back in the spotlight after another comical attempt against one of our reports.
The scenario is similar: they make up straw-men and give them a naive beatdown with a lot of laughable BS show off. But this one is a legendary performance that needs to become a classic reference.

I peed my pants a little from the first paragraph:

What this means is that for a week, these useless nitwits ran the debunk without even getting the incriminated study right.
Like how do they even breathe… ah, wait, they’re maskers…

After a bunch of fill in because they’re paid by word, they land their only point and argument:

To claim the 1918-1919 flu pandemic deaths were caused by bacterial pneumonia alone is inaccurate.

Reuters

I bolded “alone” because that’s how they attempt to “virus” the discussion.

No one said “alone” before them and no one made the claim they are arguing.
So no, they debunked a claim they themselves made up. Or did they?
More so, in exactly the paragraph that precedes their argument, they 200% CONFIRMED the claim that went viral:

See anyone saying “alone”?

Fauci makes it very clear in his description of the study that bacterial pneumonia was preceded by the influenza virus: “The weight of evidence we examined from both historical and modern analyses of the 1918 influenza pandemic favors a scenario in which viral damage followed by bacterial pneumonia led to the vast majority of deaths. In essence, the virus landed the first blow while bacteria delivered the knockout punch.” (here).

Reuters

That part bolded in Fauci’s quote is our claim, it proves the official narrative was BS for over a century and now we have Reuters to vouch for it. Thank you, Reuters, we couldn’t advance The Great Awakening so fast if you NPCs weren’t polar opposites to genius! 😉

And guess what, they can’t even beat their own strawman, because the flu may have started something in 1918, but bacteria ALONE delivered the knockout punch. And there would be no knockouts is it wasn’t for knockout punches, ya kno…

So, maybe to claim the 1918-1919 flu pandemic deaths were caused by bacterial pneumonia alone is NOT that inaccurate. If someone breaks your legs and someone else takes advantage later to kill you, only the latter goes to jail for homicide. And, to be honest, I could use more evidence on the lethal contribution of that first viral blow.

Children can debunk a Reuters debunk

As for the mask connection, science has not definitively demonstrated the direct causal relationship between masks and the 1918 bacterial pneumonia pandemic, but, based on the knowledge available so far, masks are generally associated with higher bacterial risk, from candida to “maskne”. So don’t tell people to look elsewhere, if you find a better culprit, first write a paper and get the Nobel you deserve. Until then, we have all the reasons to point at masks as a very likely suspect and demand much more caution. No one has even attempted that paper in quite a while because no one’s been that dumb, but we can always hope that from Reuters.

… BUT IF YOU’RE HERE MOST LIKELY YOU’RE NOT 😉

By the way, call that “anecdotal” or whatever, but my home country, Romania, has been officially birthed through a series of very large mass gatherings with no masks and no distancing, precisely during the 1918 pandemic. And I have all the reasons to think that lack of masks is what kept them safe, the pandemic being hardly noticed locally, at the time.

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

#StopStealingOxygen

Meet Tony “I have no evidence and I’ve just said the opposite, but I’m saying it anyway and media gonna amplify it” Fauci.
I have a Nobel Prize and a cohort of top experts to back me up when I say he’s a fraud, I have the receipts, I have Fauci himself, what does YouTube and the Silly Valley have, besides Stalinism and a massive oxyneurodeficience?

Is your IQ positive? 8min test: How many times did Fauci admit making shit up without any evidence?

UPDATE:

… AND THEN…

AND EVEN MORE SO…

I am proud of this one…
… and of this one

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

This historical photo document that sits as cover for this article has made a few rounds of the Internet so far and it isn’t stopping. Dupes and covidiots came up with the most hilarious dismissals, but the problem is “believers” couldn’t come up with any background info either, so it all appears as controversial. Let’s end this situation.

Top billionaires hold secret meeting

May 21, 2009, NBC News

In a quiet meeting closed to the news media and the public, Bill Gates, David Rockefeller Sr., Oprah Winfrey and other leading philanthropists met in New York this month to discuss ways to promote efforts to solve growing social problems in America and abroad.

Together, the philanthropists in the room have committed a total of more than $72.5 billion to charitable causes since 1996, according to Chronicle of Philanthropy tallies.

The unusual event was held May 5 at Rockefeller University and was organized by the Bill & Melinda Gates Foundation. Among the high-profile participants were Ted Turner, Warren E. Buffett, George Soros and New York City Mayor Michael R. Bloomberg. (All of those philanthropists have appeared at one time on The Chronicle’s ranking of America’s most-generous donors.)

Several of the people at the meeting confirmed their involvement, but declined to tell The Chronicle about what was discussed or why they gathered almost in secret.

According to a person familiar with the meeting, the wealthy philanthropists gathered to trade ideas about how to raise the level of philanthropy in the world.

According to IrishCentral.com, a Web site in New York that writes about Irish Americans and which first disclosed some of the details about the gathering, each philanthropist was given 15 minutes to talk about “how they saw the future global economic climate, the future priorities for philanthropy, and what they felt the elite group should do.”

Other people who attended included Eli Broad, a real-estate investor, Julian H. Robertson, Jr., a hedge-fund manager, and Patty Stonesifer, former chief executive of the Gates foundation.


To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

by James T. Keane, Originally published by American Magasine on May 12, 2020

Dr. Anthony Fauci meets with New York City’s Regis High School students and the school’s president, Daniel Lahart, S.J., in 2019. (CNS photo/courtesy Regis High School)

We’ve just unearthed a message distributed earlier in May 2020 by Dr. Anthony Fauci, M.D., the director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health and a leading figure in the struggle to contain the coronavirus pandemic, addressed the graduating classes of 2020 at Jesuit secondary schools around the country.

Dr. Fauci testified via video before the Senate Committee on Health, Education, Labor and Pensionson Tuesday. He is observing a “modified quarantine” after coming into contact with a White House staffer who tested positive for the coronavirus.

“Currently our lives have been upended by a truly historic global pandemic. I am profoundly aware that graduating during this time—and virtually, without your friends, classmates and teachers close by—is extremely difficult,” Dr. Fauci said. “However, please hang in there. We need you to be smart, strong and resilient. With discipline and empathy, we will all get through this together.”

The video originated with a request from Daniel Lahart, S.J., president of Regis High School in New York, Dr. Fauci’s alma mater, that Dr. Fauci record a short address to the school’s graduating class. “Like most schools, we won’t be gathering in June for our usual graduation exercises,” Father Lahart told America. “As a staff, we have talked a great deal about how to mark our graduation day as special. Another Zoom just doesn’t do it.”

After another Jesuit, Jeff Johnson, S.J., president of Strake Jesuit College Preparatory in Houston (where Father Lahart was previously president), mentioned that he had a similar idea, Father Lahart contacted Dr. Fauci’s office and asked if he could do a second video that was not specific to Regis, and that could be shared with other Jesuit high schools. “It was an audacious ask of someone who is incredibly busy, and concerned with worldwide health,” Father Lahart commented. “But he speaks so easily about what his Jesuit education means to him, so I presumed it wouldn’t take him long to film either one.”

“Every Jesuit graduate can take pride in knowing that they are part of an educational system that is nearly five centuries old, and has impacted the lives or so many people around the world,” Father Lahart continued. “Today, we also can all take pride that the man who is probably the most trusted person in the United States is a graduate of a Jesuit high school and a Jesuit college. He takes great pride in his Jesuit education, and as he proudly professes, it has formed his life and his career.”


“We can all take pride that the man who is probably the most trusted person in the United States is a graduate of a Jesuit high school and a Jesuit college.”

Daniel Lahart, S.J.

Dr. Fauci was born in the Bensonhurst section of Brooklyn in 1940 and graduated from Regis High School in 1958. Applicants to the all-male Jesuit school were expected to be among the top students in their graduating class and took a rigorous entrance exam. Enrollment was kept at 140 students per class year. The school was founded in 1914 with a substantial financial gift from Julia M. Grant, the widow of New York City Mayor Hugh J. Grant. Terms of the endowment included that the school charge its students no tuition, a policy still in place today.

“I often say it was the best educational experience I could have imagined,” Dr. Fauci noted in his speech. “I became immersed in the intellectual rigor of a Jesuit education.”

Tom McCorry, a classmate of Dr. Fauci who also played with him on the Regis basketball team (Dr. Fauci was team captain in 1958) and later went on to become a college basketball coach, told America that Regis “was a very high-end academic school, just as Jesuit education in general is very high-end. We took four years of Latin, four years of Greek and a couple of years or French or German. It was quite a school, but Tony [Fauci] stood out in a number of ways.”

“He was very astute, quiet but a leader,” Mr. McCorry remembered. “He still shows it now. When all these things get thrown at him [during White House press briefings], you don’t see him losing his temper. You see him give measured answers based on the facts.”

Dr. Fauci graduated from The College of the Holy Cross in 1962, and received his medical doctorate from the Weill Medical College of Cornell University in 1966. He has served under six U.S. presidents, starting with Ronald Reagan in 1984. He noted in a 2019 visit to Regis that he was able to work under different presidential administrations because “I am almost completely apolitical.” Widely considered the top infectious disease expert in the United States, Dr. Fauci has worked on the federal response to AIDS, Zika, anthrax and Ebola, and is currently a member of the White House coronavirus task force. In 2008, Dr. Fauci was awarded the Presidential Medal of Freedom.


Dr. Fauci credited his education at Regis High School with teaching him both “precision of thought and economy of expression.”

Dr. Fauci credited his education at Regis with teaching him both “precision of thought and economy of expression,” commenting that those two habits “inform how I think, how I write and how I communicate with the public every day, especially during the present unsettling times. Just as important, however, is the Jesuit emphasis on social justice and service to others. And now is the time, if ever there was one, for us to care selflessly about one another.”

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Sometimes my memes are 3D. And you can own them. Or send them to someone.
You can even eat some of them.
CLICK HERE

Among other things, I have a 25years-long career in music. Electronic, mainly.
And one thing led to anoher…
If you think this is a joke, you are correct. If you think this is damn serious, you are sharp.

Hello World! We’re here to take over all screens with a message of love and acceptance for the Fauci Fashion phenomenon.
Too many people still prioritise brain oxygenation and freedom over Fauci Fashion and that is wrong. (We have established that oxygen fits all definitions for “drug”).
Youtube is stealing our views and we were helplessly watching our counter going backwards. That is very wrong! (good thing they don’t count Rona cases with the same accuracy and intentions)
Our muse and guiding lighthouse in Covidiocracy, Dr. Tony Fauci, gets diminished and that’s unacceptable!!! (almost used caps…)
So enough of that!
We’re asking your help to get Fauci Fashion (as seen below) into all music charts, and send out a message to everyone that we can’t be silenced. (it’s actually very doable)
Fauci Fashion is here to stay and give you Maskne! (it’s like acne, but from the mask, we’ll post links later if you need)
If you want to join the movement, read all our posts and follow your conscience. A developed conscience will know what to make of this, the rest won’t and they won’t matter 

The People for Fauci Fashion
Fauci IS Fashion

This is the introductory word to the work of an enthusiastic supporter, with all the help I and other supporters can provide. Can’t put it in words how grateful I am!
Yes, with your support, we want to attack official charts with this tune, as a way to get our voice where only Eminems and Cardi Bs can. The track is officially registered and every official stream and download counts, just use these sources.

As a music industry insider, I have the data and the method to mathematically calculate that it’s doable. We planned this carefully and we can mobilise a few thousand involved supporters that can move millions more, that can move billions. If we put together a few of your clicks with our products, know-how and strategy, we have a good shot at it.

Media is already starting to show interest, but it’s way too early to brag, we’ve just launched the initiative.

The music track (and many more)is available for free download from our Bandcamp page, this is not a business or about sales, this is about breaking a blockade. It’s “name your price” release, feel free to insert 0 if that’s the case, I still want you to have them all when you need them, even if you can’t contribute now.
We contribute what we can, when we can, IF we WANT.

And we devised a few simple and effortless ways you can get involved in our fake grassroots movement with a secret dark agenda to sabotage Covidiocracy. Because this can’t work without people like you, but can move things in the right direction with you aboard.

The short help course reads like this:
 It’s all about attention, we live in an attention economy now, we need a bit of yours to join ours and kickstart until this provides for itself. You can basically help us get more attention two main ways:
– By streaming, sharing and downloading the F out of Fauci Fashion from these official links: https://fanlink.to/cc1
– By using the Donate button on our shadow organisation’s webpage, which is right here, see the main menu on top 🙂
These funds are meant to buy ads, hire promoters and bribe media. Of course we will use most of it like Gates and Bono’s charities: in personal interest; but the rest will achieve our goals and everyone will be happy.
If you really need serious money talk: all money in the world are worthless when you have no future, like humanity under Covidiocracy. So I’m already putting everything in this work, with or without help, but it might not be enough without you. Either way, sponsoring change is the only way I can make money worth anything now.

The true Faucy Style

If you want to achieve maximum impact with your resources, here’s the details you need to know:
most efficient tools you have are
* official downloads from sites like Amazon or Juno, one track download equals 100 free streams. And one stream from a paid/premium account = about 5-6 free streams. They are also better reported and accounted too, there’s less accounts of fraud, while Youtube robbed us blind to our faces, turning back the counter;
Bundle purchases help less than individual track purchases, for some reasons related to how the charts are calculated.
* direct donations; because we have the data on how and where funds can make the best impact at a certain moment and its technically impossible to share all that knowledge and know-how.
For Paypal, use the button on this website, for cards hit the Bandcamp page, download what you like and pay what you like.
Unfortunately no crypto wallets available.
* website embeds and social shares. All platforms love that and google favors it a lot. However, Facebook hates external links, so if it’s not a paid post, it’s best to share the Facebook page itself.
Here’s a win-win trick you can do if you have a Facebook page, let’s say:
Instead of donating to us, make a dope post with the video or the Spotify player and use the money to buy promotion for it. This way you drive attention to both your page and our initiative, double win!

Soon we will devise more ways to grow this.

https://www.facebook.com/FauciFashion/

And if you really don’t like Fauci Fashion, we understand, feel free to purchase Covidiocracy T-shirts and hats from our shop. But most of those money won’t go to us, our percentage is tiny.
We don’t make any blood money on the masks, that’s manufacturer’s price.

updates:

This will most probably become like a running thread because we have interesting developments almost daily. Here are some of them

August 3rd 2020:
This happened. And even more interesting than the video is what happened when we uploaded it on Facebook, see below!

We uploaded this video on our Facebook page too and guess what happened to two people (me and a friend, in fact) the second we started to share it in private messages, verbatim copy incidents: We get locked out by Facebook who was claiming the accounts got hacked and they need to re-secure them. So we went through password changing and a whole f-ing test to regain access.
The hacking never actually happened, it was basically a false flag by Facebook, who have been long time shilling for China and Fauci.
Most of you users must have got the news that Fakebook’s just launched the new official private message censorship policy, which is basically an AI set to ban keywords and links. Much more complicated than that, but basically that. And the new toaster wasn’t set yet to the right temperature when we started to share inconvenient content.
Facebook’s pretense that two of our accounts were attacked, coincidentally and precisely when they were sharing the same video in PM’s – that’s dumb af, Suckerborg!

In other news, EDM Nations mag is with us more vigorously than China 🙂

The Swag is strong with this one

September 13th:
This escalated faster the we anticipated and we had to re-title our video to better reflect the developments:

Ever watched a heist live online? Hit the video and watch the counters.

Long story short:
Our target with The People for Fauci Fashion was 10,000 Youtube views and about as many streams on Spotify first half of September. Spotify went well since Day#1, no worries there.
First days we got the video some bumps in traffic, a solid few hundred views went away, we hardly documented it because we couldn’t believe our eyes we’re watching the counter going backwards.
We went over the shock, took it as an accident, got some more press, tricked the Facebook robots to approve our clips and literally paid Suckerborg to distribute out video across Facebook, mobilised some supporters and got things going, with a few ups and downs.
By Friday 11th we were at about 8,500 Youtube views and imaginary Champagne bottles went to the freezer before I went to bed.
Saturday morning I woke up to only about 8,900 views, I raised an eyebrow, but OK.
Before I finished my coffee we were down to around 7,300. Took me a while to process and react, mobilise some people etc, so first screenshot is from the afternoon at around 6,300 views.
Made noise, tons more people watched the video, Sunday afternoon we’re down 100 views and about 10 likes.
Regardless of what you think of our initiative, from Youtubers’ household budgets to entire industries, we all are hugely influenced by Youtube, Facebook and Twitter numbers and reports. And they are arbitrary. They insert there whatever figures they damn please. If you have doubts about that, read here how you yourself can prove Facebook is pick-pocketing users and advertisers, we learned it the hard way, and a lot more while promoting this project.

Meanwhile, reality has become even harder to distinguish from memes and parodies.


Is it a meme, is it “fake news”, is it “real news”?

By Sunday afternoon everything turned again…
#LMAO @ #Youtube: I Did a little roll call, pushed back, outed them everywhere and whatcha guess, the power is back. Not the views, though.
Did everyone just die this week-end?!
Youtube almost brags and rubs in our face the thick chunk of views they took from our video. Globalist scum, basically.

Monday: Same story reloaded, this time we kinda streamed it live on Facebook and other socials.

Before
Now



“Fauci Fashion” is part of a larger music release that has just been made available on most quality digital platforms that support electronic dance music.

Imagine a fist with five middle fingers up. Even 6 on Bandcamp or Youtube.
This is the official description of Alien Pimp’s newest EP.
Straight from the depths of the deepest Coronavirus mental and emotional depression, with one hand swinging the sword of comedy and with the other – the hammer of tragedy, here comes the sound of the “New Normal”. It’s angry, pissed, acid, deep, dark, ironic, silly, it’s everything punk aspired to be, but with computers and true care for the sound engineering. It doesn’t even matter if you like it, this EP is here to take a snap of history and set a stone. Alien Pimp did that before a few times, he pushed the bass music hybridization 10 years ago, and precisely 20 years ago he got featured on CNN for the pioneering internet as a medium for audio-visual collaborations. And now a new age awaits a new turn, especially in arts, you can be part of it or part of the past. And it’s pointless to even try stopping it, berating and belittling it, as it is pointless to ignore it. It is, it happened and it won’t go away, more so than the times that lead to its creation.
Every track comes ‘equipped” with visual support created by the musician himself. He practices something he calls “new media” or “Silview media” (from his own name and website), it’s a fusion of formats and aesthetics shaped by the current times and technology. It blends a bit of everything, from retro-futurism to memes and tiktok. Some tracks have vertical videos designed for phones, other resemble animated gifs and so forth.
In short: this is the sound o’ the times.
“Don’t like it? Imagine how much I love living the times that inspired it! Like it? You know what to do…”, says Alien Pimp.

Alien-Pimp.com

Enough blah now, this will be updated, it’s action time, thank you for everything!